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The biosynthetic-secretory pathway delivers newly synthesized molecules from the endoplasmic 
reticulum (ER) to the plasma membrane (PM), as well as to endomembrane compartments. The 
intermediate compartment (IC) is an interconnected membrane system, which mediates 
bidirectional trafficking at the ER-Golgi boundary. Besides operating in the classical secretory 
pathway, the IC also appears to participate in unconventional, Golgi-independent trafficking. 
Recent live-cell imaging studies have revealed that the IC is stably anchored next to the 
centrosome via its central domain, the pericentrosomal IC (pcIC). This novel structure, defined 
by the GTPase Rab1A, separates from the Golgi during cellular events involving centrosome 
relocation. This IC network also maintains its pericentrosomal positioning and dynamics after 
treatment with brefeldin A (BFA), a drug that results in the release of membrane-bound COPI 
coats and reversible Golgi disassembly. Thus, it was proposed that the pcIC acts as an important 
sorting site in both Golgi-dependent and -independent trafficking and therefore may be an acidic 
organelle. Based on the above findings, as well as recent results showing the persistence of the IC 
during mitosis, this study addressed the trafficking functions of this organelle throughout the cell 
cycle, with a special focus on its possible lumenal acidification.  
 
Previous studies have provided evidence that the Golgi enzyme mannosidase II (Man II) 
continuously cycles between the IC and the Golgi apparatus. Treatment of interphasic cells with 
ammonium chloride (NH4Cl) resulted in a delay in BFA-induced redistribution of Man II to the 
ER, leading to its temporary arrest in the pcIC, thus indicating that IC acidification plays a role in 
retrograde trafficking. By contrast, exposure of mitotic cells to NH4Cl effectively blocked Man II 
redistribution into the Golgi haze, resulting in its accumulation in large Rab1A-containing 
membrane clusters at metaphase. Importantly, other acidification inhibitors (chloroquine and 
bafilomycin A1), as well as BFA, gave similar effects, supporting the conclusion that the IC is an 
acidic organelle. Moreover, as the IC maintains its BFA-resistant character during cell division, 
these results raise the interesting possibility that mitotic IC clusters operate as way stations during 
the redistribution of Golgi enzymes during mitosis. Accordingly, lumenal acidification appears to 
be required for the COPI vesicle-mediated dispersal of Golgi enzymes from the IC elements into 
the mitotic Golgi haze. Low temperature (15°C) was also observed to affect the mitotic 
redistribution of Man II; however, these preliminary results need to be verified by further 
experiments. Overall, the results in this thesis provide evidence that the sorting and trafficking 
functions of the acidic IC are regulated in a cell cycle-dependent manner. 
1 Introduction 
3 
 
1.1 Overview of membrane traffic pathways 
 
The complex system of endomembranes within the eukaryotic cell allows for the separation of 
biochemical reactions from the outside environment, as well as for the division of labor between 
different intracellular compartments 1. In the 1960s and 1970s, many researchers, including the 
Nobel laureate George E. Palade, employed electron microscopy and cell fractionation to 
demonstrate that morphologically and compositionally distinct organelles perform different 
functions within a cell 1-3. Subsequent studies on the interplay between these compartments led to 
the clarification of several common principles of intracellular trafficking. These principles will be 
briefly discussed below, as they are central to the topic of this thesis. 
 
Transport between two compartments occurs via vesicular or tubular carriers that bud from a 
donor compartment and fuse with an acceptor compartment 1,2,4. Because donor and acceptor 
compartments have biochemically unique membrane compositions, it is necessary to have 
mechanisms that preserve compartment identity during active communication 1. One of these 
mechanisms is molecular sorting, which ensures that particular membrane components are either 
recruited to or excluded from the budding transport intermediates 1-3. This is accomplished via 
interaction of forward-directed cargo with cytoplasmic adaptors and coats, and via processes that 
retain resident proteins within the donor organelle 1-3. The second mechanism is vesicle targeting, 
which involves the delivery of transport intermediates to the appropriate acceptor compartment 
along cytoskeletal tracks, followed by specific membrane fusion 1-3. Several transport machinery 
proteins, such as Rab GTPases, tethering factors, and SNAREs, operate in targeting by promoting 
compartment recognition and subsequent membrane fusion 1-3,5. Membrane identity is also 
preserved by intercompartmental anterograde and retrograde pathways, of which the latter both 
recycles traffic machinery for reuse and retrieves resident proteins that have escaped from the 
donor compartment 1,2. The principles of molecular sorting, vesicle targeting, and membrane 
recycling are illustrated in Figure 1 below.
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Figure 1. Principles of intercompartmental trafficking. The key steps of intracellular membrane traffic include 
molecular sorting (1), vesicle targeting (2), and the recycling of components (3). Molecular sorting involves the 
selective recruitment of forward-directed cargo into budding transport vesicles. This may be accomplished via cargo 
receptors, which in turn interact with coat components. Molecular sorting also results in the retention of resident 
proteins in the donor compartment (not shown). Vesicle targeting involves the directed delivery of transport 
intermediates to the appropriate acceptor compartment, followed by specific membrane fusion. This process is 
accomplished by proteins present on both vesicle and target membranes, including Rabs, tethering proteins, and 
SNAREs. Finally, component recycling involves the recovery of trafficking machinery (e.g., cargo receptors or 
SNAREs) for reuse, as well as the retrieval of escaped resident proteins to the donor compartment (not shown). 
Adapted from Reference 2. 
 
1.1.1 Overview of the biosynthetic and endocytic pathways 
 
The biosynthetic-secretory pathway (Figure 2) delivers newly synthesized lipids, proteins, and 
protein-bound carbohydrates from the endoplasmic reticulum (ER) to the plasma membrane 
(PM), as well as to endomembrane compartments, such as lysosomes 6,7. This pathway is 
particularly pronounced in specialized secretory cells that release, for example, hormones or 
neurotransmitters into the extracellular space 6. During the process of translation, peptide 
sequences signal protein translocation from the cytosol into the ER lumen, where proper folding 
and preliminary covalent modification occur 6. Proteins are subsequently packaged into COPII-
coated vesicles and move to the Golgi apparatus, where they undergo a series of post-translational 
modifications, such as glycosylation and phosphorylation, catalyzed by resident Golgi enzymes 6. 
Upon reaching the most distal part of the Golgi, the trans-Golgi network (TGN), secretory 
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proteins are packaged and targeted to their ultimate destinations in the cell 6. This anterograde 
transport is balanced by retrograde pathways that return lipids and specific proteins to previous 
compartments in order to maintain the homeostasis of each organelle 6.  
 
 
Figure 2. Simplified model of intracellular traffic routes. The biosynthetic-secretory pathway (red arrows) 
delivers newly synthesized cargo from the ER to the PM or the endosomal system, while the endocytic pathway (blue 
arrows) transports internalized molecules from the cell exterior to endosomes and lysosomes for degradation. 
Recycling pathways are shown in green. For simplicity, some recycling pathways are omitted. Refer to text for more 
details. ER, endoplasmic reticulum; IC, intermediate compartment; TGN, trans-Golgi network; ERC, endocytic 
recycling compartment; COP, coat protein. Adapted from Reference 2.  
 
The endocytic pathway (Figure 2) delivers internalized molecules (e.g., nutrients, iron, 
cholesterol) from the PM to early endosomes and ultimately, lysosomes, where degradation can 
occur 6,8. Specialized cells, such as macrophages, perform a special form of endocytosis called 
phagocytosis in order to ingest and subsequently degrade microorganisms or dead cells 6. 
Endocytosis can occur via clathrin-coated pits found on the cytoplasmic surface of the PM or 
specialized cell surface invaginations called caveolae 6,8. Vesicles derived from these regions of 
the PM selectively fuse with early endosomes, where internalized cargo and cargo receptors are 
sorted to different destinations in the cell 6,9. Soluble cargo destined for degradation is released 
into the endosome lumen and transported to lysosomes via late endosomes, while cargo receptors 
are recycled back to the cell surface for reuse 6,9. Multiple recycling pathways exist from the 
endosomal system back to the PM, as well as to the TGN 6,8,10. 
1 INTRODUCTION 
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1.2 Compartments of the early secretory pathway 
 
1.2.1 Endoplasmic reticulum (ER) 
 
Since protein synthesis occurs in the cytosol, secretory and membrane proteins must contain 
signal sequences that direct their translocation across the ER membrane 1. Once inside the ER 
lumen, proteins are folded with the help of ER chaperones 6. Proper folding produces proteins 
that are competent for transport, whereas unfolded or misfolded proteins remain bound to resident 
proteins in the ER and do not exit from this compartment 1. Transport-competent proteins are 
packaged into COPII-coated vesicles located in ribosome-free regions of the ER called ER exit 
sites (ERES) 6,11.  
 
There are two models of protein export from the ER. According to the bulk flow model, forward-
directed cargo moves by default and does not require export signals 4,12,13. By contrast, the 
receptor-mediated export model states that cargo proteins contain specific signals for their 
concentration and selective recruitment into budding COPII vesicles 4,12,13. In accordance with the 
latter model, membrane proteins have been shown to contain exit signals in their cytosolic 
domains that are recognized by components of the COPII coat, while soluble cargo proteins 
possess signals recognized by transmembrane cargo receptors, which in turn are recognized by 
the COPII machinery 2,6,11,14. The wide variety of soluble secretory cargo implies the existence of 
multiple binding sites or a family of recognition proteins 2,14. 
 
1.2.2 Intermediate compartment (IC) 
 
After their budding, ER-derived transport vesicles shed their coats and fuse with pleiomorphic 
vesicular tubular clusters (VTCs), which constitute the intermediate compartment (IC) 6,11,15,16. 
The IC is an interconnected membrane network that consists of peripheral elements located 
adjacent to ERES, as well as more centrally located structures 9,14,16. The peripheral elements 
merge together to form transport complexes that move along microtubules (MTs) and fuse with 
the central IC elements, finally delivering forward-directed cargo to the cis-Golgi 6,14,16. The 
prevailing view is that the IC is a transient structure formed by homotypic fusion of COPII-coated 
vesicles 4,11,12,15,17. However, recent live-cell imaging results obtained with fluorescent IC markers 
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(ERGIC-53/p58, Rab1) have provided evidence that the IC clusters are stationary in character and 
represent the site of formation of mobile anterograde and retrograde carriers 7,17-19. The 
components of the IC are discussed in Section 1.3. 
 
A major role of the IC is to sort anterograde and retrograde traffic 11,12,15. The IC clusters possess 
COPI coats at their rims, and COPI-coated vesicles containing ER resident proteins and cargo 
receptors bud from the IC membranes, retrieving escaped ER proteins and transport machinery 
back to the ER 6,14. Soluble ER proteins contain a common tetrapeptide KDEL sequence 
recognized by KDEL receptors (KDEL-Rs), which interact with COPI coats (see Section 1.3) 
1,10,18, whereas certain integral proteins of the ER membrane contain KKXX/RRXX retrieval 
signals, which interact with COPI components directly 1,11. Multiple rounds of COPI-mediated 
retrieval results in the concentration of secretory cargo within the IC elements 4,13,14,20. However, 
it is also possible that besides retrograde trafficking, COPI-coated vesicles also function in the 
anterograde transport of proteins to the cis-Golgi 13,18. Thus, sorting into the anterograde pathway 
from the IC could be signal mediated rather than occurring by default (see Section 1.3.2) 13,18. 
The IC has also been implicated in Golgi-independent trafficking pathways, further described in 
Section 1.2.4. 
 
1.2.3 Golgi apparatus 
 
In mammalian cells, the Golgi is organized into a series of laterally linked stacks, each consisting 
of four to six flattened, membrane-limited cisternae located next to the nucleus and the 
centrosome 6,21. Cargo moving through the Golgi apparatus enters the organelle at its cis face and 
undergoes a series of covalent modifications during its transfer across the cisternal stacks 6,21,22. 
Accordingly, each cisterna is thought to contain a unique collection of processing enzymes, 
resulting in sequential processing of the cargo molecules 6,21. The exact mechanism of intra-Golgi 
transport is still a matter of debate 6,10,22. According to the vesicular transport model, cargo is 
transferred across stationary Golgi stacks via COPI-coated transport vesicles, which bud from one 
cisterna and fuse with the next 6,16,21,23. There exists a parallel retrograde pathway also based on 
COPI vesicles, which retrieve resident Golgi proteins and return them to earlier compartments 
6,23. An alternative view, the cisternal maturation model, states that the cisternae progressively 
mature and migrate through the stack as new membrane is continuously added at the cis face of 
the Golgi and peeled off at its trans side 6,20,21,23. Retrograde flow via COPI-coated vesicles 
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would be responsible for the maintenance of cisternal function by recycling enzymes back to the 
appropriate cisterna 6,20,23. A further possibility is that cisternal progression and vesicle transport 
operate in parallel 20,23. 
 
Regardless of the mechanism, proteins ultimately reach the TGN, where they are sorted and 
packaged into vesicles destined for various destinations 6,16,24. Secretory traffic can reach the PM 
either via the constitutive pathway, also known as the default pathway, or via the regulated 
pathway (see Figure 2) 6. Constitutive secretion does not require a particular signal and operates 
continuously 6. By contrast, regulated secretion involves the sorting and storage of cargo in 
secretory vesicles or granules and its release via exocytosis in response to an extracellular signal 
(e.g., hormonal stimulation) 6. There is also a third pathway involving molecules destined for 
lysosomes that operates by selective recognition in the TGN and subsequent delivery to 
lysosomes via endosomes (see Figure 2) 6. 
 
1.2.4 Non-classical secretory pathways 
 
In addition to the above described classical secretory pathway, there is evidence for pathways that 
bypass the Golgi apparatus 16,25. In certain cases, this unconventional secretion is characterized by 
its insensitivity to brefeldin A (BFA) 25. BFA is a fungal macrocyclic lactone that causes COPI 
dissociation from membranes leading to reversible Golgi disassembly and redistribution of Golgi 
enzymes to the ER 26,27. The continued transport of some molecules (e.g., cholesterol, 
sphingomyelin, and certain proteins) to the cell surface in the presence of BFA implies either 
direct contact between the ER and PM or the existence of post-ER Golgi-independent pathways 
25. The latter possibility has been previously disregarded because BFA treatment was expected to 
disrupt IC structure 25. However, recent experiments concerning IC morphology and dynamics 
have shown that this compartment is preserved as a dynamic network in drug-treated cells and 
thus can provide a direct link to the cell surface bypassing the Golgi 7. 
 
Morphologically, the IC consists of compositionally distinct vacuolar and tubular domains 
7,9,17,25,28,29. The pleiomorphic vacuolar regions contain Golgi-bound cargo as well as the cargo 
receptor ERGIC-53/p58 (described in Section 1.3.1), whereas the tubules are defined by the 
GTPase Rab1A (described in Section 1.3.4) 7,9,28. These tubules are highly dynamic and have 
been found to connect the peripheral and central IC elements, as well as establish a pathway from 
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the IC to the cell periphery 25,28. This first described peripheral Golgi bypass pathway remains 
functional in BFA-treated cells, implying that it is COPI-independent and most likely dependent 
on Rab1 function (see Figure 3 below) 9,25. A similar pathway has been previously characterized 
in yeast 30. 
 
Figure 3. Role of the IC in biosynthetic-secretory trafficking. According to this model, the IC is involved in three 
major pathways to the cell surface. Secretory cargo from the ER moves to the pcIC, where trafficking diverges into 
two pathways: the classical pathway through the Golgi apparatus to the PM (1; black arrows) and a Golgi-
independent pathway to the PM via the ERC (2; green arrows). There also exists a direct Golgi bypass route from the 
peripheral IC elements to the cell surface (3; red arrows). See text for more details. For simplicity, endocytic and 
recycling pathways are not indicated. The nucleus is shown in gray, and the centrosome in green. Note that this 
model depicts a cell in which the pcIC has separated from the Golgi. ER, endoplasmic reticulum; IC, intermediate 
compartment; pcIC, pericentrosomal IC; ERC, endocytic recycling compartment; EE, early endosome; LE, late 
endosome. Figure modified from Reference 31.  
 
The visualization of IC dynamics in living cells via a fluorescent GFP-Rab1A construct resulted 
in the identification of a novel domain of the IC located adjacent to the centrosome and 
consequently termed the pericentrosomal IC (pcIC) 7,28. While usually masked by the Golgi 
ribbon, its separation from the Golgi made it possible to identify the pcIC as a distinct structure 7. 
This separation is coupled to cellular events that involve centrosome motility or Golgi 
reorientation (e.g., cell division or migration) 7. ER-derived secretory cargo was observed to 
move toward this distinct pcIC, which is in turn connected with the Golgi via tubules 7. 
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Furthermore, the pcIC maintains its position and dynamics during BFA treatment (experimental 
Golgi disassembly) and thus was proposed to function as a way station in Golgi-independent 
trafficking (Figure 3) 7. 
 
The endocytic recycling compartment (ERC) is another organelle located next to the centrosome 
7,8,31. There are several distinct recycling pathways from the ERC to the PM involving vesicular 
or tubular carriers 8,9. These pathways mediate the recycling of internalized proteins and lipids 
back to the cell surface 8,9,31. However, many newly synthesized proteins are also known to reach 
the PM via the ERC 31. Interestingly, BFA treatment increases the overlap between the pcIC and 
ERC, which suggests the existence of a Golgi bypass pathway to the cell surface via the 
endosomal system (see Figure 3) 7,31. Direct communication between the pcIC and the ERC can 
allow for non-conventional and in some cases, even BFA-resistant pathways to the PM bypassing 
the Golgi apparatus 7,9. Importantly, the existence of a Golgi bypass pathway at the level of the 
pcIC suggests that protein sorting is initiated at a pre-Golgi location 9,31. 
 
1.3 Components of the IC 
 
1.3.1 ERGIC-53/p58 
 
Human ERGIC-53 and its rat counterpart p58 are nonglycosylated type I integral membrane 
proteins 12. ERGIC-53/p58 is highly concentrated in vesicular tubular IC clusters near the cis-
Golgi and at the cell periphery, but is also present at lower concentrations in the transitional 
elements of the ER and the cis most cisterna of the Golgi 12. It is particularly enriched in the 
vacuolar elements of the IC, but mostly absent from its tubular domain 31. ERGIC-53/p58 
functions as a cargo receptor during the transport of high mannose-containing glycoproteins from 
the ER to the IC 11,12. A carbohydrate-recognition domain in its large lumenal portion is 
responsible for glycoprotein binding, whereas binding to the COPII coat involves an ER exit 
signal that includes a diphenylalanine motif located in the cytosolic domain of the protein 12. In 
the IC, ERGIC-53/p58 releases its cargo and is recycled back to the ER via retrograde COPI-
coated vesicles 12. Correspondingly, it contains a KKXX ER targeting signal that binds to COPI 
components to mediate its recycling back to the ER 10,12. ERGIC-53/p58 and other components of 
the IC are shown in Figure 4. 
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Figure 4. Components of the IC. The four best characterized components of the IC (or IC markers) are 
p58/ERGIC-53, COPI, KDEL-R, and Rab1 (only Rab1A isoform is shown). Note that according to this model, three 
different types of COPI coats are involved in anterograde and retrograde trafficking in the early biosynthetic 
pathway. COPI-independent, Rab1A-mediated tubular pathways are also depicted. See text for more details. ERES, 
endoplasmic reticulum exit sites; IC, intermediate compartment; COPI, coat protein I; KDEL-R, KDEL receptor. 
Figure modified from Reference 10.  
 
1.3.2 COPI 
 
COPI is a heptametric complex consisting of 4 large subunits (α, β, γ, δ-COP) and 3 additional 
subunits (β’,ε, ζ-COP) 13,32. The formation of COPI vesicles is regulated by the small GTPase 
ARF1, which is in turn activated by the guanine nucleotide exchange factor (GEF) GBF1 10,13,32-
34. GBF1 first promotes ARF1 membrane insertion by stimulating GTP binding, and activated 
ARF1-GTP then recruits COPI to the membrane 13,32-34. As mentioned in Section 1.2.2, the COPI 
system is involved in the retrograde transport of escaped ER resident proteins and cargo receptors 
from the IC and cis-Golgi to the ER (see Figure 4) 14,23,32. Recent studies suggest that COPI also 
plays a role in the anterograde transport of cargo from the IC to the Golgi, indicating the 
existence of functionally distinct types of COPI vesicles (see Figure 4) 13,18,32. Within the Golgi, 
COPI-mediated retrograde transport is thought to play a role in the generation of the polarized 
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distribution of Golgi resident proteins across the cisternal stacks 20; however, the possibility that 
COPI vesicles participate in anterograde transport between Golgi cisternae cannot presently be 
excluded 23,32.  
 
There are at least 3 biochemically distinct COPI coats in mammalian cells 7,22,35. Two isotypes of 
both the γ- and ζ-COP subunits have been identified in higher eukaryotes, resulting in four 
possible combinations of the heptameric complex 32,35-37. This finding may correlate with the 
existence of distinct COPI vesicle subpopulations that form in association with the peripheral and 
central IC elements or operate within the Golgi stacks 7,21,35. Furthermore, the observed 
differential localization of the COPI subtypes suggests that the different coat complexes have 
distinct functions in the early secretory pathway 32,35. This could explain the involvement of 
different COPI coats in both anterograde and retrograde traffic within the IC, as well as the 
findings showing that COPI vesicles can contain both anterograde and retrograde marker proteins 
4,13,18,20,22,32. 
 
1.3.3 KDEL-R 
 
KDEL-R is a seven-pass transmembrane protein introduced in Section 1.2.2 32. As mentioned 
earlier, it is involved in the retrieval of escaped soluble ER resident proteins, which typically 
contain a KDEL sequence at their C-terminal ends 6,18. Ligand binding to the receptor stimulates 
its oligomerization, which is followed by its interaction with COPI components via cytosolic 
KKXX signals 32. KDEL-R rapidly cycles between the ER and Golgi, binding ER resident 
proteins in the IC and Golgi and returning them to the ER, where they are released from the 
receptor (see Figure 4) 6,16. 
 
1.3.4 Rab1 
 
Rab proteins are monomeric GTPases that play general roles in vesicle budding, targeting, and 
fusion 6,29,38. Because these proteins specifically associate with the membranes of different 
organelles, they can function as molecular markers to define organelle identity and thus guide 
traffic between them 6,29,38,39. Rab proteins cycle between an inactive GDP-bound state and an 
active GTP-bound state, which facilitates their binding to membranes 6,38,39. The activation of a 
Rab protein from a GDP-bound state to the active GTP-bound state is accomplished by 
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membrane-bound Rab GEFs 6,38. In their active state, Rab proteins can bind to various effectors, 
which play a wide range of roles in guiding coat assembly, vesicle transport, tethering, and fusion 
5,6,38. Thus, they are frequently considered as master regulators of membrane traffic. 
 
Rab1 is localized to the ER-Golgi boundary, being specifically enriched in the IC membranes 6. 
The two major effectors of Rab1, p115 and GM130, are both tethering factors that appear to 
regulate the fusion of ER-derived vesicles with the IC elements, as well as the transformation of 
the latter to cis-Golgi structures 5,7,18,39-41. Rab1 is activated by a GEF close to the ERES and has 
been suggested to recruit p115 to the forming COPII vesicles 18,39,42. Subsequently, p115 recruits 
a set of SNAREs that are required for fusion at the IC, acting as a catalyst for SNARE complex 
formation and membrane fusion 5,18,39,41,43. In the Golgi region, p115 mediates membrane 
tethering via its interaction with GM130 5,18,39,41-43. This initial membrane docking is followed by 
SNARE-mediated fusion, which is also catalyzed by p115 5,18,39,41. Thus, by regulating the 
binding of p115 and GM130, Rab1 is thought to regulate the assembly of a SNARE complex and 
subsequent vesicle fusion events at the IC and cis-Golgi 5,39. 
 
There are two Rab1 isoforms, Rab1A and Rab1B, which are both recruited to the IC membranes 
7,29. Both isoforms have been suggested to regulate anterograde transport between the ER and 
Golgi, as described; however, both are also found in tubular IC elements devoid of anterograde 
cargo, suggesting that they also function in retrograde transport to the ER 28. The Rab1A isoform 
is preferentially recruited to the tubular domain of the IC (see Figure 4), whereas the Rab1B 
isoform appears to be associated with its vacuolar part 7. As previously mentioned, Rab1A 
defines the pcIC and can be used to demonstrate its persistence after BFA treatment 7.  
 
1.4 Role of acidification in the secretory pathway 
 
1.4.1 Mechanisms of organelle acidification 
 
The compartmentalization of eukaryotic cells allows them to create unique lumenal 
microenvironments and thus localize various biochemical reactions to specific intracellular 
compartments 44,45. The catalytic activity of enzymes within these organelles is influenced by the 
intralumenal pH, which is optimal for the processing events that occur within a particular 
organelle 44,45. Organelle acidification provides a mechanism to regulate optimal function of 
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many intracellular compartments, including endosomes, lysosomes, secretory granules, and the 
TGN 44,45. Acidification is also required for the efficient sorting and trafficking of molecules 
along the endocytic and biosynthetic pathways 45. Disruption of organelle acidification has been 
linked to complex diseases such as cancer, as well as genetic disorders such as Dent’s disease and 
cystic fibrosis 45. 
 
Steady state pH of an organelle is maintained by a balance between proton pumping to the lumen, 
proton leak, and counterion conductance 44,45. Vacuolar H+-ATPases (V-ATPases) pump protons 
from the cytosol to the lumen of membrane-bound organelles harnessing the energy derived from 
ATP hydrolysis 44,46. The variable density of pumps in different intracellular membranes, as well 
as modification of the activity of individual V-ATPase complexes, contribute to the observed pH 
differences of various organelles 46. Moreover, proton pumping is counterbalanced by the 
intrinsic proton leak of a particular compartment membrane 44,46. Differences in counterion 
permeability (e.g., chloride) additionally influence the extent of proton accumulation by affecting 
the membrane potential of a compartment 44,46. Finally, second messengers may also play a role 
in pH regulation, and as a result, organelle pH may be influenced by the physiological state of the 
cell 46. 
 
1.4.2 pH of the secretory pathway 
 
The measurement of pH within organelles of the secretory pathway has been difficult because the 
compartments are not easily accessible to external pH-sensitive probes that are internalized by 
endocytosis 46. Several techniques have been employed, including DAMP labeling and expression 
of pH-sensitive variants of GFP (such as pHluorin), which contain organelle-specific targeting 
sequences 45,46. The ER is generally assumed to be neutral, having an approximate pH of 7.2 
similar to the pH of the cytosol 46. Subsequent compartments of the secretory pathway are 
thought to be more acidic, with the pH gradually decreasing from 6.7 in the cis-Golgi to 6.0 in the 
TGN 46. Acidification of the TGN is important for protein sorting, as well as for the formation of 
secretory granules 44,45. Notably, however, only the TGN and secretory granules have been 
convincingly demonstrated to be acidic compartments 45. 
 
Whether low pH contributes to the function of earlier secretory compartments is less clear. 
Acidification has been shown to be important for the steady state localization of Golgi resident 
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proteins (e.g., glycosyltransferases) 47,48. It also seems to play a role in retrograde trafficking in 
the early secretory pathway. pH neutralization by the V-ATPase inhibitor bafilomycin A1 was 
shown to selectively disrupt BFA-induced retrograde transport of the Golgi enzyme mannosidase 
II, resulting in its arrest in IC structures 45,49. In addition, the IC has been found to contain an 
active V-ATPase 50, and DAMP staining has revealed that at least some of the centrally located 
IC elements are indeed acidic 45,49. These results provide evidence for IC acidification and its role 
in retrograde trafficking 49. The identification of the pcIC and its emerging role in protein sorting 
raise the question of its lumenal pH. Indeed, recent studies have shown that acidification 
inhibitors block the BFA-induced redistribution of Golgi components at the level of the pcIC, 
indicating that low pH is important for the function of this compartment in protein sorting 7. 
 
1.4.3 Possible role of low pH in function of the IC 
 
Although the current evidence for IC acidification is inconclusive, it is an attractive possibility, 
especially considering the multiple roles of this compartment in molecular sorting. A possible 
interplay between sorting and IC acidification is exemplified by the cycling of KDEL-R 6. In 
order to be able to bind escaped soluble ER resident proteins in the IC and cis-Golgi and to 
release them in the ER, the affinities of the receptor for the KDEL sequence must differ in the 
two compartments 6. Thus, in the IC and cis-Golgi, where ER residents are most likely found at 
low concentrations, the receptor must display a high affinity for the KDEL motif 3,6,32. On the 
other hand, it must have a low affinity for the sequence in the ER in order to release its cargo 
3,6,32. Differential acidification of the early secretory compartments may play an important role in 
determining the affinity of KDEL-R for proteins containing the KDEL sequence 6,32. In 
accordance with this idea, in vitro studies have shown that the binding of KDEL-R to the KDEL 
motif increases at lower pH 18,51. 
 
In addition, differences in pH may be important for the dissociation of cargo proteins from 
recycling cargo receptors (e.g., ERGIC-53/p58) 18. A lower pH in the IC may trigger the 
dissociation of cargo-receptor complexes, since neutralization of organelle pH has been shown to 
prevent the dissociation of ERGIC-53 and the cargo glycoprotein procathepsin Z 18,52. 
Furthermore, the binding of ERGIC-53 to its glycoprotein cargo is calcium-dependent, and low 
calcium concentrations appear to increase the sensitivity of ERGIC-53 to pH 10,18. Some studies 
have demonstrated high calcium levels in the Golgi and ER, but the lumenal calcium 
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concentration of the IC remains unknown 18,53. One possibility is that low calcium levels and low 
pH together promote cargo release in the IC lumen 18,53. 
 
1.4.4 Inhibitors of organelle acidification 
 
Organelle acidification can be affected by various acidification inhibitors, such as weak bases, 
ionophores, and V-ATPase inhibitors 44. Weak bases (e.g., chloroquine and ammonium chloride) 
are amine-containing membrane permeant compounds that disrupt organelle pH by accumulating 
in acidic compartments, where they become protonated and subsequently impermeant 45. Proton 
ionophores, such as the Na+/H+ exchanger monensin, rapidly dissipate proton gradients in 
endocytic and biosynthetic compartments 45. Finally, macrolide antibiotics, such as bafilomycin 
A1, dissipate the pH gradient by directly inhibiting V-ATPase activity 45,46. 
 
The main problem with pH perturbants is that they cannot selectively disrupt the pH of individual 
compartments, and they most likely have indirect effects on other cellular processes 44. For 
example, weak bases disrupt osmolarity and cause compartment swelling and vacuolarization 45. 
In addition, because these treatments affect the pH of all acidified compartments, they may give 
rise to secondary effects 45. For instance, disrupting the pH gradient in the TGN may also affect 
earlier steps in the secretory pathway 45. Consequently, results from experiments utilizing these 
compounds should always be interpreted with caution. 
 
1.5 Secretory pathway during mitosis  
 
Successful cell division depends on duplication and equal partitioning of not only the genome, 
but also of intracellular organelles 40. Because of the essential role of the Golgi apparatus in 
protein glycosylation, lipid biosynthesis, and secretory trafficking, its proper inheritance during 
mitosis is crucial for cellular homeostasis and function 40. As a result, the mechanism of 
mammalian Golgi division is carefully coordinated with cell cycle progression 40.  
 
According to the prevailing model, mitotic Golgi division involves several consecutive steps, 
which are briefly discussed below. During early prophase, the recruitment of COPII to ER 
membranes is blocked by a currently unknown mechanism, resulting in the inhibition of ER 
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export 54-57. The Golgi ribbon is then laterally fragmented, and the cisternal stacks undergo 
further disassembly during prometaphase 40,56,58. The resulting Golgi fragments (also known as 
mitotic Golgi clusters) are then transformed into a collection of vesicles and tubules during 
metaphase, resulting in the formation of a so-called mitotic Golgi haze 40,42,54,56,58-60. In parallel 
with chromosome segregation, these mitotic Golgi clusters are equally partitioned between the 
forming daughter cells 40,56. Mitotic Golgi disassembly is reversible, and the Golgi fragments 
again coalesce to reform two functional daughter Golgis at cytokinesis 40,56,59.  
 
1.5.1 Mechanisms of mitotic Golgi disassembly  
 
The mechanisms of lateral unlinking, cisternal unstacking, and further breakdown of the Golgi 
into vesicles and tubules depend on the phosphorylation of tethering factors such as GRASP65 
and GM130 by the mitotic kinases CDK1/cyclin B, MEK1, and PLK1 40,54,58,61. GRASP65 is an 
important tethering factor that connects Golgi stacks laterally into a ribbon and links adjacent 
cisternae within a stack together via its ability to homo-oligomerize 5,39,40,56,62. Phosphorylation of 
GRASP65 by CDK1 during late G2/early prophase disrupts oligomerization, resulting in 
disassembly of the Golgi ribbon and breakdown of connections between adjacent cisternae 
5,39,40,42,56,62,63. In turn, unstacking dramatically increases the area available for vesicle budding, 
possibly enhancing the COPI-dependent vesiculation process 39,40,56. Consequently, by 
metaphase, the isolated stacks rapidly disperse into the mitotic Golgi clusters via increased 
formation of COPI vesicles 39,40,63. Golgi fragmentation can also proceed in a COPI-independent 
manner, involving the transformation of cisternae into extensive tubular networks 4,33,40,64. 
 
Golgi disassembly is also promoted by mitotic inhibition of vesicle tethering and fusion, 
mediated by CDK1-dependent phosphorylation of GM130 5,39,40,43,54,56,61. During interphase, 
GM130 is recruited to Golgi membranes via its association with GRASP65 and interacts with the 
cytosolic factor p115, which is bound to giantin on COPI vesicles 5,39-43,54,55,58. This GM130-
p115-giantin complex brings the two membranes together and catalyzes vesicle fusion 5,39-41,43. 
During mitosis, GM130 phosphorylation interferes with the formation of this complex, leading to 
the inhibition of COPI vesicle docking and fusion, which in combination with increased vesicle 
budding and the inhibition of ER export, results in rapid fragmentation and dispersal of the Golgi 
during metaphase 5,39,40,42,43,54,56,58. 
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1.5.2 Golgi partitioning  
 
There are two general models for mitotic Golgi partitioning, which differ in their definition of the 
nature of the mitotic Golgi haze 40,58,65. According to one model, Golgi resident proteins are 
absorbed into the ER as cells progress to metaphase and are then released to reassemble the 
daughter Golgis at cytokinesis 40. This model is based on the assumption that Golgi resident 
enzymes continuously cycle between the ER and Golgi during interphase, as suggested by live-
cell imaging of GFP-fused proteins 27,40,58,59. When ER export was blocked by the expression of a 
GDP-bound mutant of Sar1p, which arrests COPII vesicle budding, Golgi residents were seen to 
accumulate in the ER, resulting in Golgi disassembly 27,40,59. During mitosis, the inhibition of ER 
export could result in similar entrapment of Golgi enzymes in the ER 40,58. The inhibition of 
anterograde traffic with the continuation of retrograde trafficking would lead to a redistribution of 
Golgi enzymes to the ER, thus contributing to mitotic Golgi disassembly 59. At the end of mitosis, 
the resumption of ER export would allow the reformation of new Golgis in the separating 
daughter cells 59. Thus, this model suggests that the Golgi is not an autonomous organelle when it 
comes to inheritance and that it employs the ER for its partitioning 65. However, this model has 
been criticized because the rate of recycling of Golgi components during interphase is too slow to 
explain their efficient relocation to the ER during the early stages of mitosis 55. Whether mitosis 
affects the kinetics of retrograde transport remains unknown 58.  
 
An alternative model maintains that the Golgi and ER remain as distinct compartments 
throughout mitosis, i.e., that they are inherited independently 40,66. Rather than merging with the 
ER, the Golgi clusters instead break down by continuous budding of small COPI vesicles 40,66. 
Depending on the cell type, the clusters and/or vesicles persist throughout mitosis and function as 
the partitioning units of the organelle 40,59,65. This model is partly based on the finding that after 
BFA treatment and subsequent washout in the presence of a Sar1 mutant that inhibits COPII 
vesicle formation (thus blocking ER exit), Golgi matrix proteins (e.g., GRASPs) appear to be able 
to reform the Golgi independently of Golgi membrane proteins 56,65,67. Furthermore, matrix 
protein-containing structures have been found to partition between the daughter cells during 
metaphase in the apparent absence of Golgi enzyme-containing membranes 65. This suggests that 
Golgi matrix proteins serve as a scaffold for membranes containing Golgi residents and that 
independent partitioning of this matrix during metaphase ensures accurate Golgi reassembly at 
the end of mitosis 56,65. The two models of Golgi partitioning are shown in Figure 5 below. 
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Figure 5. Two popular models of Golgi partitioning. As described in the text, the perinuclear Golgi ribbon of 
interphasic cells is disassembled into mitotic Golgi clusters by a process of ribbon unlinking and cisternal unstacking 
due to the phosphorylation of Golgi tethering factors by mitotic kinases. Golgi components present in these clusters 
are then either redistributed to the ER (1) or dispersed by COPI-mediated vesiculation (2), resulting in their 
characteristic diffuse localization (“Golgi haze”) at metaphase. Figure modified from Reference 58. 
 
During metaphase, matrix proteins and Golgi membranes have been observed to accumulate 
around the spindle poles, while the ER is excluded from the region of the spindle 54-56. This 
suggests that the spindle machinery may be responsible for the partitioning of mitotic Golgi 
clusters 40,54,55,65,66. Interestingly, the spindle has been found to be required for the partitioning of 
factors needed for Golgi ribbon reassembly, whereas components of polarized and functional 
Golgi stacks can be inherited independently of the spindle 56,66. Overall, these findings suggest 
two distinct mechanisms of Golgi inheritance. Firstly, minimally functional Golgi stacks can be 
inherited in a spindle-independent manner 56,66 via a partitioning mechanism that depends on 
Brownian motion of Golgi matrix structures 55,65. Golgi enzymes may either utilize the matrix 
structures to reach the daughter cells, or they may be partitioned via the ER, as described above 
for the alternative model 65. Secondly, the spindle regulates the partitioning of additional factors 
that enable the linkage of Golgi stacks into a continuous ribbon 56. 
 
1.5.3 Golgi reassembly  
 
Golgi reassembly is essentially a reversal of the disassembly process, involving membrane fusion 
and cisternal restacking 40,59. GM130 dephosphorylation at the end of mitosis results in the 
reformation of functional GM130-p115-giantin complexes, which mediate vesicle tethering and 
membrane fusion 40. Following successful fusion events, p115 and GRASP65 can promote 
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restacking of cisternae and the linkage of individual stacks into a ribbon 40.  
 
Golgi reassembly typically begins at telophase and results in the formation of two separate 
structures at opposite sides of the nucleus in each daughter cell 40,56,60. The larger of these 
structures is positioned next to the centrosome at the distal side of the nucleus, while the smaller 
cluster is located in the midbody region between the forming cells, suggesting that the Golgi may 
have a role in the final abscission event during cytokinesis 40,56,60. During the late stage of 
cytokinesis, the smaller Golgi cluster migrates to the opposite side of the nucleus and merges 
with the larger structure to form the final Golgi ribbon 40,60. Notably, this coalescence is not 
synchronous, indicating that it may be related to other asynchronous events that take place during 
late cytokinesis (e.g., events affecting the centrosomes or cytoskeleton) 60.  
 
1.5.4 Possible role of the IC in Golgi partitioning  
 
In addition to the actin-based contractile ring, membrane traffic is known to be required for the 
separation of daughter cells during cytokinesis 40. It has been suggested that the Golgi apparatus, 
as well as the recycling endosomes, contribute to the delivery of membranes to the cleavage 
furrow to facilitate the final abscission event 8,68. However, cells are able to progress through 
mitosis in the presence of BFA, which results in Golgi disassembly 40. Because the pcIC is a 
BFA-resistant structure that is functionally connected with the recycling endosomes 7, it could 
also function in membrane traffic events that result in the completion of cytokinesis. Furthermore, 
recent live-cell imaging studies of IC dynamics in GFP-Rab1A-expressing NRK cells have 
suggested a novel role of the IC in the partitioning of Golgi membranes during mitosis (M. Marie, 
H. Dale, N. Kouprina, J. Saraste, manuscript in preparation). 
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Recent live-cell imaging studies have shown that the IC persists during mitosis, suggesting that 
this compartment could participate in Golgi disassembly and the partitioning of Golgi 
components. Therefore, the overall goal of this master project was to further characterize the role 
of the IC in membrane traffic throughout the cell cycle, with a special focus on its lumenal 
acidification. 
 
The following specific aims were set in order to study the role of the IC in protein trafficking in 
interphasic and mitotic cells: 
 
1. To investigate how acidification inhibitors affect bidirectional trafficking at the ER-Golgi 
boundary during interphase. 
 
2. To evaluate the effect of acidification inhibitors on the redistribution of Golgi enzymes during 
mitosis using mannosidase II (Man II) as a marker protein. 
 
3. To obtain further insight on the mechanisms of Golgi partitioning during mitosis and the 
possible role of the IC in the redistribution of Golgi components. 
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Tables 1-17 provide a list of all reagents, solutions, cell lines, antibodies, drugs, technical 
equipment, software, and other materials used in the experiments. 
 
3.1 Reagents 
 
3.1.1 General 
 
Table 1. Basic laboratory reagents used in the various experiments. 
Reagent Abbreviation/Formula Specifications Supplier 
Disodium hydrogen phosphate 
dihydrate 
Na2HPO4 ⋅ 2H2O Pro-analysis grade (p.a.) Merck, Darmstadt, Germany 
Dulbecco’s phosphate buffered 
saline 
PBS Modified without CaCl2 and 
MgCl2 
Sigma-Aldrich, Steinheim, 
Germany 
Ethanol EtOH Absolute Sigma-Aldrich 
Glucose (D (+)-glucose 
monohydrate) 
- - Merck 
Glycerol - 99% Sigma-Aldrich 
Glycine H2NCH2COOH p.a. Merck 
Hydrochloric acid HCl - Sigma-Aldrich 
Hydroxyethylpiperazine 
ethanesulfonic acid  
HEPES Minimum 99.5% Sigma-Aldrich 
Methanol MeOH p.a. Fluka, Buchs, Switzerland 
MilliQ water - - Millipore, Oslo, Norway 
Paraformaldehyde PFA Reagent grade Sigma-Aldrich 
Potassium chloride KCl p.a. Merck 
Saponin - - Sigma-Aldrich 
Sodium chloride NaCl p.a. Merck 
Sodium dihydrogen phosphate 
monohydrate 
NaH2PO4 ⋅ H2O p.a. Merck 
Sodium hydroxide NaOH p.a. Merck 
Sucrose C12H22O11 - Merck 
Tris(hydroxymethyl)-amino 
methane 
Tris p.a. Merck 
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3.1.2 Cell culture 
 
Table 2. Reagents used in cell culture. 
Reagent Abbreviation Specifications Supplier 
Dimethylsulphoxide DMSO - Sigma-Aldrich 
Dulbecco’s modified Eagle’s 
medium, 1x 
DMEM Containing 1 g/L D-glucose, 
L-glutamine, and sodium 
pyruvate 
Gibco, Invitrogen, Grand 
Island, NY, USA 
Fetal bovine serum FBS Heat inactivated Gibco, Invitrogen 
Ham's F12 nutrient mixture F12 Containing L-glutamine Gibco, Invitrogen 
L-glutamine, 100x L-glu 200 mM Sigma-Aldrich 
Penicillin-streptomycin, 100x Pen-strep 5000 units/ml penicillin 
5 mg/ml streptomycin 
 
Sigma-Aldrich 
Poly-L-lysine - Minimum 98% Sigma-Aldrich 
Trypsin-EDTA, 1x - - Gibco, Invitrogen 
 
3.1.3 Immunofluorescence and confocal imaging 
 
Table 3. Reagents used in immunofluorescence and confocal imaging. 
Reagent Abbreviation Specifications Supplier 
Bovine serum albumin BSA Fraction V ≥96% Fluka 
Goat serum GS Heat inactivated Gibco, Invitrogen 
Guanidine hydrochloride Guanidine >99.5% Sigma-Aldrich 
Sodium azide  Na-azide - Sigma-Aldrich 
Vectashield mounting 
medium 
- With DAPI Vector Laboratories, 
Burlingame, CA, USA 
 
3.1.4 Cell fractionation 
 
Table 4. Reagents used in cell fractionation. 
Reagent Abbreviation Specifications Supplier 
Complete Mini protease 
inhibitor cocktail 
- EDTA-free Roche Diagnostics, 
Mannheim, Germany 
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Ethylenediamine tetraacetic 
acid 
EDTA 99% Sigma-Aldrich 
Ethyleneglycerol tetraacetic 
acid 
EGTA Minimum 97% Sigma-Aldrich 
Hank’s balanced salt solution HBSS - Gibco, Invitrogen 
OptiPrep - Iodixanol 60% stock solution 
in H2O 
Axis-Shield AS, Oslo, Norway 
Protease inhibitor cocktail 
(chymostatin, leupeptin, 
antipain, pepstatin) 
CLAP Stock solution containing 10 
mg/ml of each 
Sigma-Aldrich 
 
3.1.5 SDS-PAGE 
 
Table 5. Reagents used in SDS-PAGE. 
Reagent Abbreviation Specifications Supplier 
Acrylamide/ bisacrylamide 
solution, 30% 
- Electrophoresis purity Bio-Rad, Hercules, CA, USA 
Ammonium persulfate APS For electrophoresis, ≥98% 
pure 
Sigma-Aldrich 
Beta-mercaptoethanol - Electrophoresis purity Bio-Rad 
Bromophenol blue - Electrophoresis purity Bio-Rad 
N,N,N’,N’-
tetramethylethylene diamine 
TEMED - Bio-Rad 
Ponceau S - - Fluka 
Precision Plus™ protein 
standard 
- - Bio-Rad 
Sodium dodecylsulfate SDS Electrophoresis purity Bio-Rad 
 
3.1.6 Western blotting 
 
Table 6. Reagents used in Western blotting. 
Reagent Supplier 
Difco nonfat dry milk Becton Dickinson, Sparks, MD, USA 
SupersignalWestPico Chemiluminescent Substrate Thermo Fisher Scientific, Rockford, IL, USA 
Tween20 Sigma-Aldrich 
 
3.2 Solutions 
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3.2.1 Immunofluorescence 
 
Table 7. Solutions for immunofluorescence.  
Solution Abbreviation Total volume Components Special instructions 
0.2 M phosphate 
buffer, pH 7.2 
- 100 ml 28 ml of 0.2 M 
NaH2PO4 ⋅ H2O (27.6 g 
in 1 L dH2O) 
72 ml of 0.2 M 
Na2HPO4 ⋅ 2H2O (35.6 
g in 1 L dH2O) 
Adjust pH to 7.2. 
Paraformaldehyde, 3% 
(w/v)  
3% PFA 100 ml 3 g of PFA 
50 ml of dH2O 
50 ml of 0.2 M 
phosphate buffer 
Add 5 drops of NaOH 
and warm solution to 
60°C under constant 
mixing until clear. Add 
phosphate buffer and 
filter solution. Store at 
4°C. 
Washing buffer (1x 
PBS with 0.2% (w/v) 
BSA and Na-azide) 
WB 400 ml 400 ml of 1x PBS 
800 mg of BSA 
400 µl of Na-azide 
Store solution at 4°C. 
Washing buffer + 0.2% 
(w/v) saponin 
WBS 200 ml 400 mg of saponin 
200 ml of WB 
Filter solution and store 
at 4°C. 
Blocking buffer (5%  
(v/v) goat serum + 
WBS) 
BB 10 ml 500 µl of goat serum 
10 ml of WBS 
 
 
Filter solution using 
syringe capped with 
sterile filter (0.22 µm 
pore size) and store at 
4°C. 
 
3.2.2 Cell fractionation 
 
Table 8. Solutions for cell fractionation. 
Solution Total volume Components  Special instructions 
1 M Tris-HCl, pH 7.5 1 L 121.1 g of Tris 
800 ml of dH2O 
Adjust pH to 7.5 with HCl. 
Bring volume to 1 L with 
dH2O. Store at 4°C.  
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Homogenization buffer (for 
OptiPrep™) (130 mM KCl, 25 
mM NaCl, 1 mM EGTA, 25 
mM Tris-HCl, pH 7.5) 
200 ml 5 ml of 1 M NaCl (57.3 g in 1 
L dH2O) 
5 ml of 1 M Tris-HCl, pH 7.5 
1.94 g of KCl 
76 mg of EGTA 
Bring volume to 200 ml with 
dH2O. 
Washing buffer (for 
OptiPrep™) (140 mM NaCl, 
30 mM KCl, 10 mM EDTA, 
25 mM Tris-HCl, pH 7.5) 
200 ml 28 ml of 1 M NaCl  
5 ml of 1 M Tris-HCl, pH 7.5 
447 mg of KCl 
1.17 g of EDTA 
Bring volume to 200 ml with 
dH2O. 
HEPES-EDTA buffer, pH 7.4 
(10 mM HEPES, 1 mM 
EDTA) 
200 ml 477 mg of HEPES 
117 mg of EDTA 
Bring volume to 200 ml with 
dH2O. Adjust pH to 7.4 with 
HCl. 
Homogenization buffer (for 
glycerol gradients) (50 mM 
NaCl, 10 mM HEPES, 1 mM 
EDTA, pH 7.4) 
200 ml 10 ml of 1 M NaCl 
 
Bring volume to 200 ml with 
HEPES-EDTA buffer, pH 7.4. 
Washing buffer (for glycerol 
gradients) (250 mM sucrose, 
10 mM HEPES, 1 mM EDTA, 
pH 7.4) 
200 ml 17.1 g of sucrose 
 
Bring volume to 200 ml with 
HEPES-EDTA buffer, pH 7.4. 
 
3.2.3 SDS-PAGE 
 
Table 9. Solutions for SDS-PAGE. 
Solution Total volume Components Special instructions 
0.5 M Tris-HCl, pH 6.8 100 ml 6 g of Tris 
60 ml of dH2O 
Adjust pH to 6.8 with HCl. 
Bring volume to 100 ml. Store 
at 4°C. 
1.5 M Tris-HCl, pH 8.8 150 ml 27.23 g of Tris 
80 ml of dH2O 
Adjust pH to 8.8 with HCl. 
Bring volume to 150 ml. Store 
at 4°C. 
SDS, 10% (w/v) 100 ml 10 g of SDS  
90 ml of dH2O 
Bring volume to 100 ml. 
APS, 10% (w/v) 1 ml 100 mg of APS Dissolve in 1 ml of dH2O. 
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10% resolving gel 10 ml (for 2 gels) 4.1 ml of dH2O 
2.5 ml of 1.5 M Tris-HCl, pH 
8.8 
3.3 ml  of 30% acrylamide/bis 
0.1 ml of 10%  SDS 
50 µl of 10% APS 
5 µl of TEMED 
Add 10% APS and TEMED 
immediately prior to pouring 
the gel. 
4% stacking gel 10 ml (for 2 gels) 6.1 ml of dH2O 
2.5 ml of 0.5 M Tris-HCl, pH 
6.8 
1.3 ml  of 30% acrylamide/bis 
0.1 ml of 10% SDS 
50 µl of 10% APS 
10 µl of TEMED 
Add 10% APS and TEMED 
immediately prior to pouring 
the gel. 
10x electrophoresis buffer 1 L 30.3 g of Tris 
144 g of glycine 
10 g of SDS 
800 ml of dH2O 
Adjust volume to 1 L with 
dH2O. Store at 4°C. 
1x electrophoresis buffer (25 
mM Tris, 192 mM glycine, 
0.1% SDS) 
1 L 100 ml of 10x electrophoresis 
buffer 
Adjust volume to 1 L with 
dH2O. 
Sample buffer, 2x 10 ml 3.55 ml of dH2O 
1.25 ml of 1 M Tris-HCl, pH 
6.8 
2.5 ml of glycerol 
2.0 ml of 10% SDS 
0.2 ml of 0.5% (w/v) 
bromophenol blue 
Add 50 µl of beta-
mercaptoethanol prior to use.  
 
3.2.4 Western blotting 
 
Table 10. Solutions for Western blotting. 
Solution Abbreviation Total volume Components Special instructions 
1 M Tris-HCl, pH 7.5 - 1 L 121.1 g of Tris 
800 ml of dH2O 
Adjust pH to 7.5 with 
HCl. Bring volume to 1 
L with dH2O. Store at 
4°C. 
Transfer buffer (25 mM 
Tris, 190 mM glycine, 
10% methanol) 
- 1 L 3.03 g of Tris 
14.4 g of glycine 
100 ml of MeOH 
500 ml of dH2O 
Adjust volume to 1 L 
with dH2O. 
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Washing buffer (20 
mM Tris-HCl, pH 7.5, 
150 mM NaCl, 0.1% 
Tween) 
TBS-Tween 1 L 20 ml of 1 M Tris-HCl, 
pH 7.5 
150 ml of 1 M NaCl 
(57.3 g in 1 L dH2O) 
1 ml of Tween 20 
Adjust volume to 1 L 
with dH2O. 
Blocking buffer (5% 
(w/v) milk/TBS-
Tween) 
- 100 ml 5 g of nonfat dry milk 
80 ml of TBS-Tween 
Adjust volume to 100 
ml with TBS-Tween. 
 
3.3 Cell lines 
 
Table 11. Cell lines used in the experiments. 
Cell line Abbreviation Supplier 
Baby hamster kidney cells expressing triple 
hemagglutinin (HA)-tagged wildtype 
CFTR 
BHK WT-CFTR M. Sharma, Reference 69 
Normal rat kidney cells NRK parental ATCC 
NRK GFP-Rab1A cells NRK GFP-Rab1A M. Marie, Reference 7 
 
3.4 Antibodies 
 
3.4.1 Antibodies for immunofluorescence 
 
Antibody incubations were carried out for 2 hours at RT, unless otherwise indicated. The 
secondary antibodies were Texas Red (TxR) and fluorescein isothiocyanate (FITC) conjugates. 
 
Table 12. Antibodies used in immunofluorescence. 
Antibody Stock concentration Dilution Source 
Mouse anti-HA tag 1 mg/ml 1:100 Nordic Biosite, Copenhagen, 
Denmark 
Mouse anti-Man II 5-7 mg/ml 1:250 (3% PFA + 6 M 
guanidine - 5 min or methanol 
fix) 
Nordic Biosite 
Rabbit anti-β-COP 4.4 mg/ml 1:500 Affinity Bioreagents, Golden, 
Colorado, USA 
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Rabbit anti-Man II Serum 1:250 Kelley Moremen, University 
of Georgia, Athens, Georgia, 
USA 
Rabbit anti-p58 Serum 1:200 Randy Schekman, Univesity of 
California, Berkeley, CA, USA 
Rabbit anti-p58 Purified IgG 1:20 Affinity purified from serum, 
Reference 70 
Rabbit anti-Rab1 Purified IgG 1:20 o/n Affinity purified from serum, 
Bruno Goud, Institute Curie, 
Paris, France 
FITC-coupled goat anti-mouse 
IgG 
2 mg/ml 1:50 Jackson Immuno Research, 
West Grove, PA, USA 
FITC-coupled goat anti-rabbit 
IgG 
2 mg/ml 1:50 Jackson Immuno Research 
TxR-coupled goat anti-mouse 
IgG 
2 mg/ml 1:50 Jackson Immuno Research 
TxR-coupled goat anti-rabbit 
IgG 
2 mg/ml 1:50 Jackson Immuno Research 
 
3.4.2 Antibodies for Western blotting 
 
Table 13. Antibodies used in Western blotting. 
Antibody Stock concentration Dilution Source 
Rabbit anti-Man II Serum 1:500 (o/n) Kelley Moremen 
Rabbit anti-p58 Serum 1:5000 (o/n) Randy Schekman 
Rabbit anti-Rab1 Purified IgG 1:500 (o/n) Bruno Goud 
HRP-coupled goat anti-rabbit 
IgG (light chain specific) 
0.8 mg/ml 1:5000 (2 h) Jackson Immuno Research 
 
3.5 Drugs 
 
Table 14. Drugs used in the experiments. 
Product Abbreviation/Formula Specifications Supplier 
Ammonium chloride NH4Cl ≥99.5% Sigma-Aldrich 
Bafilomycin A1 Baf A1 ≥90% from Streptomyces 
griseus 
Sigma-Aldrich 
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Brefeldin A BFA >99% from Eupenicillium 
brefeldianum 
Epicentre Biotechnologies, 
Madison, WI, USA 
Chloroquine diphosphate salt CQ - Sigma-Aldrich 
Cycloheximide CHX - Calbiochem, Darmstadt, 
Germany 
Monensin sodium salt - - Sigma-Aldrich 
 
3.6 Technical equipment 
 
Table 15. Technical equipment used in the experiments. 
Instrument Specifications Supplier 
Ball bearing cell cracker (homogenizer) Ball size 8.010 mm EMBL Precision Engineering, Heidelberg, 
Germany 
Beckman swinging bucket rotor SW41 Beckman, Palo Alto, CA, USA 
Beckman ultracentrifuge Optima LE-80K TL-100  Beckman 
Benchtop centrifuge 5810, 5810 R Eppendorf, Hamburg, Germany 
Biofuge - Heraeus Instruments, Germany 
Confocal Leica TCS SP2 AOBS 63x objective Leica Microsystems, Wetzlar, Germany 
Electrophoresis power supply  PowerPac 300 Bio-Rad 
Horizontal shaker MMPV 15 Heto-Holten AS, Allerød, Denmark 
Inverted light microscope Olympus CKX31 Olympus, UK 
Liquid nitrogen tank Locator 8 Thermo Fisher Scientific 
Luminescent Image Analyzer LAS-3000 Fujifilm, Tokyo, Japan 
Milli-Q Ultrapure water purification 
system 
- Millipore, Oslo, Norway 
Mini Protean® 3 Cell Electrophoresis 
Module 
- Bio-Rad 
Mini Trans-Blot® Electrophoretic Transfer 
Cell 
- Bio-Rad 
Steri-cycle CO2 incubator With HEPA filter Thermo Forma, Marietta, OH, USA 
Thermomixer - Eppendorf 
Water bath - Stuart Scientific, UK 
 
3.7 Software 
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Table 16. Software used for data analysis and image composition. 
Program Specifications Supplier 
Excel Microsoft Office X for Macintosh Microsoft, Redmond, WA, USA 
ImageJ - NIH, Bethesda, MD, USA 
Image Reader LAS-3000 Version 2.2 Fujifilm 
Leica LAS Image Analysis - Leica Microsystems 
Photoshop Version 7.0.1 Adobe Photoshop, San Jose, CA, USA 
 
3.8 Other materials 
 
Table 17. Other materials used in the experiments. 
Product Specifications Supplier 
Cell culture dishes 6-well, 12-well MedProbe, Oslo, Norway 
Cell culture flasks 25 cm², 75 cm², 300 cm² MedProbe 
Cell scraper 25 cm Sarstedt, Germany 
Centrifuge tubes 500 µl, 1.5 ml Eppendorf 
Centrifuge tubes 15 ml, 50 ml Sarstedt 
Circular glass coverslips 18 mm Ø 
Thickness 0.17 ± 0.01 mm 
Chemi-Teknik AS, Oslo, Norway 
Comb - Bio-Rad 
Cryotubes - Nunc, Denmark 
Fiber pads - Bio-Rad 
Microscopic objective slides 76 x 26 mm Chemi-Teknik AS 
Nitrocellulose membrane 0.2 µm pore size Schleicher & Schuell, Dassel, Germany 
Outer glass plate, 1 mm Mini Protean 3 Bio-Rad 
pH indicator strips pH 5-10 Merck 
Short plate Mini Protean 3 Bio-Rad 
Syringe, Plastipak 10 ml Becton Dickinson SA, Madrid, Spain 
Syringe filter, Acrodisc 25 mm with 0.2 µm HT Tuffryn 
membrane 
Pall Corporation, Ann Arbor, MI, USA 
Ultra-clear centrifuge tubes SW41 Beckman 
Whatman filter paper 0.92 mm thickness Whatman, England 
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The methods described in the following section were employed in experiments involving 3 
different cell lines. Refer to Materials (Section 3) for preparation of various solutions. 
 
4.1 Cell culture 
 
All cell culture work, including drug treatments and experimental manipulations, was performed 
under sterile conditions. All solutions used for the procedures described were either sterilized 
before use or purchased as sterile.  
 
4.1.1 General maintenance 
 
Cultured cells (NRK parental, NRK GFP-Rab1A) were grown to 70-90% confluency in 25 cm² or 
75 cm² polystyrene culture flasks equipped with filter caps. Cells were grown in an incubator at 
37ºC and 5% CO2 in DMEM supplemented with 10% heat inactivated FBS, 50 IU/ml penicillin, 
50 µg/ml streptomycin, and 2 mM L-glutamine. BHK WT-CFTR cells were grown in 1:1 DMEM 
and F12 medium supplemented with 5% heat inactivated FBS, 50 IU/ml penicillin, 50 µg/ml 
streptomycin, and 2 mM L-glutamine. 
 
4.1.2 Thawing of cells 
 
Cells stored in liquid nitrogen (-196ºC) were retrieved from the nitrogen tank and thawed initially 
under running tap water  and further thawed on ice for approximately 5 min. The cell suspension 
(1 ml) was then transferred into a 15 ml centrifuge tube containing 9 ml of pre-cooled (4°C) 
complete culture medium, and the solution was centrifuged at 1000 rpm for 5 min in a bench top 
centrifuge. After centrifugation, the DMSO-containing supernatant was removed by suction, and 
the cells were resuspended in 5 ml of fresh pre-warmed (37°C) medium and plated in 25 cm² 
culture flasks at the appropriate dilution. The culture flasks were then transferred to the CO2 
incubator. 
 
4.1.3 Passage of cells 
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The cells were routinely passaged (every 2-3 days) after reaching approximately 70-90% 
confluency, as determined by examination with a light microscope using phase contrast optics. 
Cells were washed once with 3-5 ml of PBS, and 0.5-1 ml of pre-warmed (37°C) trypsin-EDTA 
was added. The cells were then incubated in the CO2 incubator for approximately 3 min in order 
to allow the cells to partially detach; detached cells have a characteristic round appearance when 
observed under a light microscope. The cells were completely detached from the substratum by 
hitting the side of the flask several times. 5 ml of fresh medium were then added to the cells, and 
the cell aggregates were disrupted by pipetting the cell suspension up and down a few times. The 
cell suspension was then diluted 1:5, 1:10, 1:20, or other dilution variations in fresh pre-warmed 
(37°C) culture medium and resuspended to ensure an even distribution. 
 
4.1.4 Freezing of cells 
 
Cells growing in 25 cm² culture flasks were amplified, trypsinized, and resuspended in growth 
medium, as previously described. Cell suspensions were then centrifuged for 5 min at 1000 rpm, 
and the supernatant was removed by suction. The cell pellet was resuspended in ice-cold 1:10 
DMSO-containing medium, and the suspension was aliquoted at 1 ml into labeled cryotubes. 
DMSO is a cryoprotectant that prevents cellular rupture at low temperatures. The tubes were 
placed for 3 hours in the -20°C freezer, followed by overnight freezing at -80°C. The next day, 
the tubes were transferred to the liquid nitrogen tank for storage.  
 
4.1.5 Plating of cells on coverslips 
 
Pre-washed glass coverslips were placed into 6- or 12-well culture dishes and allowed to dry. Cell 
suspensions were obtained as previously described and diluted in complete medium (e.g., 1:10). 2 
ml volumes were added to each well. The cells were allowed to grow for at least 24 h prior to 
beginning experiments in order to reach confluency. 
 
In the case of mitotic shake-offs (described in Section 4.2.2), coverslips were coated with 100 µl 
of poly-L-lysine (diluted 1:10 in dH2O) for 10 min and subsequently washed 3x with sterile 
dH2O. 100 µl of cell suspensions were added to the coverslips, and the cells were allowed to bind 
on ice for approximately 10 min prior to fixation or further manipulation. 
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4.2 Experimental manipulations 
 
4.2.1 Drug treatments 
 
The following treatments listed in Table 18 were used for cells at 70-90% confluency, grown on 
coverslips in culture dishes or in culture flasks at 37°C in complete DMEM. 
 
Table 18. Drugs used in the experiments. 
Drug Abbreviation/Formula Stock concentration Working concentration 
Ammonium chloride NH4Cl 1 M stock in H2O 10 mM (1:100) 
Bafilomycin A1 Baf A1 100 µM stock in EtOH 0.5 µM (1:200) 
Brefeldin A BFA 5 mg/ml stock in EtOH 5 µg/ml (1:1000) 
Chloroquine CQ 10 mM stock in H2O 100 µM (1:100) 
Cycloheximide CHX 10 mg/ml stock in PBS 50 µg/ml (1:200) 
Monensin - 1 mM stock in EtOH 1 µM (1:1000) 
 
4.2.2 Mitotic shake-offs 
 
Mitotic shake-offs were done in order to collect and concentrate the mitotic cells on coverslips for 
easier identification and quantification. Drug treatments were conducted as shown in Table 18 
and done prior to the shake-offs (i.e., done in culture flasks at 70-90% confluency). Mitotic cells 
were released by hitting the side of the flask, followed by examination under a light microscope. 
The cell suspensions containing the mitotic cells were collected, placed on ice, and centrifuged 
for 5 min at 1000 rpm. After centrifugation, the supernatant was removed by suction, and the cell 
pellets were resuspended in 100-200 µl of complete medium or HBSS. 100 µl of cell suspension 
were added to coverslips pre-coated with poly-L-lysine on ice, as described in Section 4.1.5. 
Alternatively, cell suspensions of mitotic cells were subjected to cell fractionation techniques (see 
Section 4.4). 
 
4.2.3 Low temperature treatments 
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Low temperature treatments were performed with steady state cultures grown in culture flasks, as 
well as with mitotic shake-offs. For the steady state cultures, the medium was replaced with 
medium containing 20 mM HEPES, pH 7.2 pre-cooled to 15°C in a water bath. The culture flasks 
were then incubated in a 15°C water bath. Mitotic shake-offs were performed immediately 
following low temperature incubation in order to collect the mitotic cells, which were then plated 
on poly-L-lysine-coated coverslips. Alternatively, mitotic cells were collected prior to low 
temperature incubation, plated on coverslips, and then subjected to low temperature treatment. 
For cell fractionation studies, cell suspensions containing mitotic cells were transferred into 50 ml 
tubes and pelleted at 1000 rpm for 5 min. The pellets were then resuspended in 50 ml total of 
medium containing 20 mM HEPES, pH 7.2 pre-cooled in a 15°C water bath. The samples were 
incubated at 15°C and then centrifuged at 1000 rpm for 5 min in a pre-cooled (4°C) centrifuge. 
The pellets were resuspended in 10 ml of ice-cold HBSS and processed for cell fractionation and 
velocity sedimentation in Opti-Prep™ gradients as described in Section 4.4.2. 
 
4.3 Immunofluorescence staining and confocal microscopy 
 
4.3.1 Principle 
 
Immunofluorescence microscopy is a technique used to detect proteins in tissue samples and 
cultured cells. Samples are first incubated with purified antibodies that recognize particular 
epitopes, and the primary antibodies are in turn recognized by secondary antibodies coupled to 
fluorescent dyes (e.g., FITC). The protein of interest is then localized by excitation of the 
fluorescent molecule with an appropriate wavelength of light, followed by detection of the 
emission signal. Double-labeling immunofluorescence can be used to compare the distribution of 
two different proteins in a cell by using two secondary antibodies coupled to different fluorescent 
dyes. 
 
Confocal microscopy is a special type of fluorescence microscopy that has high resolution and 
optimal contrast. Figure 6 highlights the basic components of a confocal microscope. The unique 
feature is the presence of two pinholes that allow transmitted light to be focused. As shown in the 
figure, the laser beam passes through an illuminating aperture prior to reaching the surface of the 
specimen so that only a small portion of the sample is illuminated. In turn, the emitted 
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fluorescence passes through a confocal aperture prior to reaching the photodetector in order to 
reject out-of-focus light. The composite image is then displayed on a computer screen. 
 
 
Figure 6. Principles of confocal fluorescence microscopy. (A) The basic components of a confocal microscope are 
illustrated in the figure. Note the presence of two confocal pinholes. The illuminating aperture ensures that only a 
small part of the specimen is illuminated by the laser by focusing the beam on the specimen surface. The emitted 
fluorescence reaches the photodetector by passing through a dichroic mirror. The presence of a confocal aperture 
ensures that only in-focus light reaches the detector (B), while out-of-focus light is excluded (C). This contributes to 
the high resolution and contrast of confocal fluorescence microscopy. Figure modified from Reference 6. 
 
4.3.2 Sample preparation 
 
As described in Section 4.1.5, samples were plated on coverslips at least 24 h prior to the start of 
the experiment and allowed to reach a confluency of 70-90%. After the treatments (see Section 
4.2), cells were fixed for 30-60 min at RT with 1 ml of 3% PFA prepared in 0.1 M phosphate 
buffer, pH 7.2. After fixation, the cells were washed 2x with 2 ml of washing buffer (PBS 
containing 0.2% BSA) and permeabilized/blocked for at least 15 min in 1 ml of blocking buffer 
(5% goat serum, 0.2% saponin, 0.2 % BSA in PBS). The cells were then incubated at RT with 40 
µl of pre-cleared (5 min, 13000 rpm in a biofuge) primary antibody diluted in blocking buffer 
(see Section 3.4.1, Table 12 for the appropriate dilutions and durations). The primary antibody 
was removed by washing 2x with washing buffer containing 0.2% saponin (2 ml), followed by a 
third time for 2 h. The secondary antibody (FITC- or TxR-conjugated goat anti-rabbit or -mouse 
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fragment antigen binding ( F(ab) ) fragment) was diluted 1:50 in blocking buffer and pre-cleared; 
40 µl were added to the coverslips for 2 h. The secondary antibody was then washed out as 
described overnight. Finally, the cells were washed 1x with PBS and mounted onto objective 
slides using Vectashield® mounting medium containing DAPI.  
 
Alternatively, cells were fixed for 10 min at -20°C with 1 ml of pre-cooled methanol (-20°C) and 
washed extensively on ice with washing buffer (PBS containing 0.2% BSA). The samples were 
subsequently incubated with primary and secondary antibodies diluted in blocking buffer without 
saponin. Table 12 (Section 3.4.1) describes the specific fixation protocols for each antibody used. 
The samples were mounted as described. 
 
4.3.3 Image acquisition 
 
The cells were examined using a Leica TCS SP2 AOBS confocal system equipped with a 63x/1.4 
NA Plan Apochromat oil immersion objective, ~1.2 airy unit pinhole aperture, and appropriate 
filter combinations. The lasers used were blue diode (405 nm - DAPI), argon/krypton (488 nm - 
GFP and FITC/514 nm - YFP), and helium neon (594 nm - TxR) lasers. When visualizing 
samples double-stained with two fluorophores, the presence of cross-excitation and -emission 
was verified prior to imaging. This was done by testing one laser at a time, and if both emission 
signals appeared, the fluorophores were determined to be cross-emitting. In order to avoid this, 
the sequential scanning mode was then selected. For imaging and quantification, a representative 
area was randomly selected from the whole area of the coverslip. After the images were acquired, 
they were further processed using Adobe Photoshop version 7.0 or analyzed using standard Leica 
confocal software (see Section 4.7).  
 
4.4 Cell fractionation 
 
All steps were performed on ice using pre-cooled solutions, and all centrifugations were 
performed at 4°C. An overview of the procedure is presented in Figure 7. This method was an 
adaptation for NRK cells from a protocol developed for PC12 cells 71. 
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Figure 7. Overview of cell fractionation. See text below for more details. Figure modified from Reference 6. 
 
4.4.1 Principle 
 
Cell fractionation is a method that allows for the separation of organelles from a population of 
cells. It consists of two principal steps, which must be performed at cold temperatures in order to 
minimize damage to molecules from cellular enzymes. The first step is the homogenization of 
cells using a homogenizer, which breaks cellular membranes and releases organelles. The next 
step is purification, which is accomplished by differential centrifugation and/or equilibrium 
sedimentation. Differential centrifugation involves a sequential increase in gravitational force that 
results in the sequential separation of organelles as a function of their density. Larger and denser 
structures pellet at lower centrifugal forces, whereas smaller organelles remain in the supernatant. 
As a result, one can sequentially isolate and remove whole cells, nuclei, mitochondria, lysosomes, 
etc. The resulting total membrane fractions can be further separated by equilibrium 
sedimentation, which relies on solution gradients (e.g., glycerol) in order to separate structures 
based on their individual densities. Upon centrifugation, each organelle settles in a gradient 
comparable to its own density; this allows ultraprecise separation of structures. 
 
4.4.2 Experimental protocol using iodixanol gradients (Opti-Prep™) 
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4.4.2.1 Homogenization of cells 
 
The following protocol is described for parental NRK cells grown to 70-90% confluency in ten 
300 cm2 culture flasks and passaged the previous day. After the treatments (see Section 4.2), 
mitotic cells were collected by shake-off (see Section 4.2.2) into 50 ml tubes. The cells were 
pelleted at 1000 rpm for 5 min in a pre-cooled (4°C) bench top centrifuge, and the pellets were 
resuspended in 10 ml of HBSS. The suspensions were combined into two 50 ml tubes and each 
filled to 50 ml with HBSS. The cells were pelleted again, and the pellets were resuspended in 15 
ml total of washing buffer (140 mM NaCl, 30 mM KCl, 10 mM EDTA, 25 mM Tris-HCl, pH 
7.4). The samples were centrifuged as before and resuspended in 0.5-1 ml of homogenization 
buffer (130 mM KCl, 25 mM NaCl, 1 mM EGTA, 25 mM Tris-HCl, pH 7.4) supplemented with 
protease inhibitors (1x CLAP and 1 tablet of Complete Mini per 10 ml of buffer). The pellets 
were kept on ice. 
 
The cell homogenizer equipped with a 8.010 mm diameter stainless steel ball in its chamber was 
assembled as previously described in Reference 71 and washed with homogenization buffer before 
use. The cell suspension was passed through the homogenizer approximately 20-30 times by 
pressing the pistons of the two attached 1 ml syringes. Samples of the cell suspension before and 
after homogenization were viewed using phase contrast optics in an inverted microscope (20-40x) 
in order to ensure that the cells were homogenized adequately. The homogenates were then 
centrifuged at 600 x g for 10 min at 4°C to pellet the nuclei and cell debris. The post-
chromosomal supernatants were recovered into a 1.5 ml Eppendorff tube and kept on ice. 
 
4.4.2.2 Preparation of iodixanol gradients and equilibrium sedimentation 
 
The iodixanol gradients were prepared immediately prior to centrifugation as detailed in Table 19 
by mixing varying volumes of homogenization buffer (without protease inhibitors) and 50% 
iodixanol (Opti-Prep™) stock solution. The gradients were obtained by carefully pipetting the 
different mixtures on top of each other from highest to lowest concentration (1.2 ml of each) into 
a SW41 ultracentrifuge tube. 0.8 ml of sample was then pipetted on top of each gradient. The 
tubes were balanced to 0.1 g accuracy and centrifuged at 4°C for 30 min at 150,000 x g in the 
Beckman LE-80K ultracentrifuge using the SW41 rotor. After centrifugation, 8 fractions (~1.2 ml 
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each) were collected from the top and diluted with homogenization buffer up to 11.5 ml. The 
fractions were then centrifuged for 1 h at 100,000 x g in the ultracentifuge. After centrifugation, 
the supernatant was removed, and the pellets containing the membranes were resuspended in 50-
100 µl of homogenization buffer supplemented with protease inhibitors and frozen in 10-20 µl 
aliquots at -80°C. The samples were subsequently analyzed by SDS-PAGE and Western blotting 
(see Sections 4.5 and 4.6). 
 
Table 19. Preparation of 5-25% iodixanol gradients. 
% iodixanol 50% iodixanol Homogenization buffer 
5% 0.50 ml 4.50 ml 
7.5% 0.75 ml 4.25 ml 
10% 1.00 ml 4.00 ml 
12.5% 1.25 ml 3.75 ml 
15% 1.50 ml 3.50 ml 
17.5% 1.75 ml 3.25 ml 
20% 2.00 ml 3.00 ml 
22.5% 2.25 ml 2.75 ml 
25% 2.50 ml 2.50 ml 
 
4.4.3 Experimental protocol using glycerol gradients 
 
4.4.3.1 Homogenization of cells 
 
Each gradient was prepared from mitotic shake-offs (see Section 4.2.2) of parental NRK cells 
grown to 70-90% confluency in eight 300 cm² culture flasks. The cells were passaged the 
previous day into complete DMEM containing high glucose (4500 mg/L) in order to increase the 
mitotic index. Following treatments (see Section 4.2), the mitotic cells were collected by shake-
off and pipetted into 50 ml tubes on ice. Cells were pelleted by centrifugation for 5 min at 1000 
rpm. The cells were then washed with HBSS by first resuspending each pellet in 5 ml of HBSS 
and then combining the pellets from each condition into a corresponding 50 ml tube. The tubes 
were filled to 50 ml with HBSS and centrifuged for 5 min at 1000 rpm. The pellets were then 
resuspended in 5 ml of washing buffer (250 mM sucrose in HEPES-EDTA buffer, pH 7.4) and 
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transferred to 15 ml tubes. Washing buffer was added to yield a final volume of 15 ml. The cells 
were then centrifuged again for 5 min at 1000 rpm. The supernatant was discarded, and the 
pellets were kept on ice. The procedure was repeated for a second shake-off from the flasks. 
 
The pellets were resuspended in 0.5-1 ml of homogenization buffer (50 mM NaCl, 10 mM 
HEPES, 1 mM EDTA, pH 7.4 supplemented with Complete Mini and 1x CLAP) and combined 
with the corresponding pellet from the second shake-off, followed by homogenization (see 
Section 4.4.2.1). The homogenates were then centrifuged at 600 x g for 10 min at 4°C. The post-
chromosomal supernatants were recovered into 1.5 ml Eppendorff tubes and kept on ice. 
 
4.4.3.2 Preparation of glycerol gradients and equilibrium sedimentation 
 
50% glycerol (in HEPES-EDTA buffer, pH 7.4) was mixed with HEPES-EDTA buffer in order 
to make solutions for each of the 5-25% glycerol gradients (see Table 20). 
 
Table 20. Preparation of 5-25% glycerol gradients. 
% glycerol 50% glycerol HEPES-EDTA buffer 
5% 0.50 ml 4.50 ml 
7.5% 0.75 ml 4.25 ml 
10% 1.00 ml 4.00 ml 
12.5% 1.25 ml 3.75 ml 
15% 1.50 ml 3.50 ml 
17.5% 1.75 ml 3.25 ml 
20% 2.00 ml 3.00 ml 
22.5% 2.25 ml 2.75 ml 
25% 2.50 ml 2.50 ml 
 
0.8 ml of 80% (w/v) sucrose (in HEPES-EDTA buffer, pH 7.4) was added to the bottom of two 
SW41 ultracentrifuge tubes. The gradients were prepared by sequential pipetting (1.1 ml) of the 
glycerol solutions on top of each other from highest to lowest concentration. 0.8 ml of sample 
was then carefully pipetted on top of each gradient, and the tubes were balanced to 0.1 g 
accuracy. Velocity gradient centrifugation was carried out in a Beckman SW41 rotor at 150,000 x 
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g for 30 min at 4°C. 
 
After centrifugation, 9 fractions (~1.2 ml each) were collected from the top and each diluted to 
11.5 ml with ice-cold PBS in separate ultracentrifuge tubes. The separate fractions were 
centrifuged for 60 min at 100,000 x g in the SW41 rotor in order to concentrate the membranes. 
The membrane pellets were resuspended in 50-100 µl of homogenization buffer supplemented 
with Complete Mini and 1x CLAP. The resuspended membranes were then divided into 10-20 µl 
aliquots and frozen at -80°C to be subsequently analyzed by SDS-PAGE and Western blotting 
(see Sections 4.5 and 4.6). 
 
4.5 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
 
SDS-PAGE was used in order to separate proteins present in membrane fractions obtained by cell 
fractionation, as described in Section 4.4. 
 
4.5.1 Principle 
 
SDS-PAGE is a technique that allows for the separation of proteins in an applied electric field 
based on size; the proteins can be subsequently visualized by staining or further analyzed by 
immunoblotting. Acrylamide provides a support matrix for protein migration and forms a porous 
gel upon polymerization in the presence of a cross-linking reagent (bisacrylamide). The 
percentage of acrylamide in a gel determines the pore size, which affects the migration of 
proteins through the gel. A high polyacrylamide concentration allows the gel to separate smaller 
proteins, while a low concentration allows for the separation of larger molecules. 
 
Because proteins are amphoteric compounds that may have a net positive or negative charge 
depending on the pH of the solution, overall protein separation is determined by both size and 
charge. However, treatment with an anionic detergent such as SDS denatures proteins and gives 
them a uniform charge per unit length so that they migrate toward the positive electrode in an 
electric field based on their molecular size. 
 
4.5.2 Sample preparation 
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The following protocol is described for the Mini Protean 3 Cell Electrophoresis Module from 
Bio-Rad. Cell fractionation samples were diluted in 1:2 in sample buffer (see Section 3.2.3, 
Table 9). Samples were then boiled for 5 min at 95°C (or 15 min at 56°C) in a thermomixer 
before loading onto the gel. 
 
4.5.3 Electrophoresis 
 
The Mini Protean 3 Cell Electrophoresis Module (Bio-Rad) was assembled according to the 
instruction manual, and the 1 mm thick gel was prepared immediately prior to use. The thick gel 
consisted of a resolving gel and an overlying stacking gel (see Section 3.2.3, Table 9). The 
resolving gel was poured in between the glass plates and allowed to polymerize for 45-60 min 
before adding the stacking gel. The purpose of the stacking gel was to concentrate the protein 
sample into a sharp band before entering the resolving gel. 20 µl of each sample and 10 µl of 
Precision Protein Standard™ (Bio-Rad) containing a mixture of pre-stained markers were then 
loaded into the appropriate wells. Electrophoresis was carried out in 1x electrophoresis buffer 
(0.1% SDS, 25 mM Tris, 192 mM glycine). The gel was run for ~45 min at 200 V. The resolving 
gel was then incubated for 10 min in transfer buffer containing 10% methanol prior to transfer to 
a nitrocellulose membrane (Section 4.6). 
 
4.6 Western blot analysis 
 
Western blotting was used to detect proteins of interest separated by SDS-PAGE. 
 
4.6.1 Principle 
 
Western blotting, also known as immunoblotting, is a method used to detect the presence of 
specific proteins after separation by SDS-PAGE. It consists of two main steps: the electrophoretic 
transfer of proteins from the polyacrylamide gel to a nitrocellulose membrane and the detection 
of the protein of interest using a specific antibody. The principles of antibody staining in Western 
blots are similar to those of immunofluorescence. However, the secondary antibody is commonly 
coupled to horseradish peroxidase (HRP), which allows protein visualization using 
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chemiluminescent detection methods. When the immunoblot is incubated with a 
chemiluminescent agent, the substrate is cleaved by HRP to generate a reaction product, which 
produces luminescence in proportion to the amount of protein. This light is then detected by a 
special camera that captures a digital image of the blot. 
 
4.6.2 Protein transfer to nitrocellulose 
 
The following protocol is described for the Mini Trans-Blot Electrophoretic Transfer Cell from 
Bio-Rad. The resolving gel was soaked in cold transfer buffer (25 mM Tris, 190 mM glycine, 
10% methanol), along with two pieces of Whatman filter paper, a nitrocellulose membrane, and 
two fiber pads. The transfer apparatus was assembled in the following order: fiber pad, Whatman 
filter paper, SDS gel, nitrocellulose membrane (pore size 0.2 µm), Whatman filter paper, and 
fiber pad. Air bubbles were removed, and the transfer was carried out at 100 V for 60 min in an 
immunoblot tank assembled according to the manufacturer’s instructions. 
 
Following transfer, the membrane was washed for 30 min in TBS-Tween (20 mM Tris-HCl, pH 
7.5, 150 mM NaCl, 0.1% Tween) and subsequently stained with Ponceau S (0.1% in 5% acetic 
acid) in order to verify protein transfer and to aid with excision into lanes. Each lane was 
transferred into a separate well and stained with a particular antibody (see Section 3.4.2, Table 
13). 
 
4.6.3 Protein detection/immunostaining 
 
Ponceau S was washed out with TBS-Tween for 30 min. Each strip of membrane was then 
incubated in 2 ml of blocking buffer (TBS-Tween containing 5% dry milk) for 1 h at RT in order 
to block unspecific antibody binding. The primary antibody was diluted in blocking buffer as 
described in Table 13 (see Section 3.4.2) and added to the nitrocellulose membrane (1.5 ml) for 
overnight incubation at 4°C. The next day, the membrane was washed for 2 h with blocking 
buffer and then incubated for 2 h with the secondary antibody coupled to HRP diluted in blocking 
buffer (see Section 3.4.2, Table 13). The membrane was washed for 1 h with TBS-Tween. 
 
In order to detect the antibody-labeled proteins, the membrane was incubated with 4 ml of 
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Supersignal® WestPico chemiluminescent substrate (kit solutions mixed 1:1) for 5 min. The 
immunoreactive bands were visualized using a Luminescent Image Analyser LAS-3000 dark box. 
The length of exposure time varied from 30 sec to 10 min, depending on the strength of the 
signal. 
 
4.7 Data analysis and quantification 
 
For quantification, cells were counted from the whole coverslip or a representative area of the 
coverslip. Statistical analyses were performed using Excel. The data were expressed as a mean ± 
standard deviation or as a total number per coverslip. 
 
For pixel intensity quantifications, standard Leica confocal software was used to define regions of 
interest (ROIs), and the total fluorescence intensity for the appropriate channel was calculated for 
the summed optical sections/z-stacks. The total fluorescence was divided by the area of the ROIs 
to yield a pixel intensity per unit area. Background fluorescence was also measured and 
subtracted from the total fluorescence intensity. 
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Stable expression of a GFP-coupled construct of Rab1A in NRK cells allowed the identification 
of a novel domain of the IC, which associates with the centrosome and thus is designated as the 
pericentrosomal IC (pcIC) 7. This domain is normally masked by the Golgi ribbon but can be 
identified as a distinct structure during cellular events that involve centrosome relocation, e.g., at 
the onset of mitosis 7. Subsequent studies revealed that the pcIC receives cargo proteins from the 
ER and is resistant to treatment of cells with BFA, which releases COPI coats and results in 
complete Golgi disassembly 7. Importantly, these studies have also demonstrated that protein 
transport to the PM still occurs in the presence of BFA, suggesting a role for the pcIC in Golgi-
independent trafficking 7. The increased overlap between the pcIC and the centrosome-associated 
ERC after BFA treatment suggested that the pcIC and ERC together form a stable 
pericentrosomal membrane system (PCMS) that functions as a way station during PM delivery of 
newly synthesized proteins bypassing the Golgi 7. Thus, the pcIC may operate as an important 
sorting site in both Golgi-dependent and -independent trafficking to the cell surface 7. Because of 
the known role of acidification in protein sorting, e.g., within the endosomal system and the 
TGN, it was of interest to investigate its importance in trafficking via the pcIC.  
 
5.1 Effect of pH neutralization on BFA-induced redistribution of mannosidase II 
in interphasic cells 
 
In these experiments, the trafficking of the medial Golgi enzyme mannosidase II (Man II) via the 
pcIC was investigated in NRK cells. Previous studies of interphasic cells showed that the pcIC 
contains a variable pool of Man II, indicating that this protein continuously cycles between the 
Golgi and the IC, using the pcIC as a way station 7. Furthermore, BFA causes the redistribution of 
Man II from the Golgi to the ER via the pcIC, which persists in drug-treated cells 7. Assuming 
that the pcIC is an acidic compartment, the disruption of its lumenal pH with acidification 
inhibitors would be expected to affect protein trafficking at the level of this organelle. Therefore, 
the following experiments addressed whether the BFA-induced redistribution of Man II is 
inhibited by various compounds that are known to result in the neutralization of acidic organelles.  
 
Figure 8 shows the BFA-induced redistribution of Man II in the presence of the neutralizing 
agent ammonium chloride (NH4Cl). Steady state cultures of GFP-Rab1A-expressing NRK cells 
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were pretreated for 3 h with NH4Cl (10 mM), whereafter BFA (5 µg/ml) was added to the 
medium for 10 or 30 min in the continued presence of NH4Cl. Long-term pretreatment with the 
acidification inhibitor was chosen due to the observed effect of neutralization on pcIC tubulation 
(data not shown). Control samples were treated for 10 or 30 min with BFA only. As shown in 
Figure 8A (control), already after 10 min of BFA treatment, the  Golgi apparatus has fully 
disassembled, as indicated by the absence of Golgi-type Rab1A and Man II labeling, and Man II 
assumes an ER-like distribution. Consistent with previous results 7, the pcIC remains as a distinct 
Rab1A-containing structure in the presence of the drug. In contrast, pretreatment with NH4Cl 
results in the accumulation of Man II in the pcIC, as indicated by the colocalization of Rab1A and 
Man II in the perinuclear area of cells treated with BFA for 10 min. This finding indicates that 
NH4Cl at least partially inhibits the BFA-induced redistribution of Man II from the Golgi to the 
ER and that the protein becomes arrested in the pcIC. Notably, after 30 min treatment with BFA, 
the amount of Man II accumulating in the pcIC, as indicated by the red fluorescence signal, 
appears to be reduced compared to 10 min of drug treatment, suggesting that NH4Cl does not 
completely block Man II redistribution, but rather causes a delay.  
 
Quantification of the number of cells showing Man II accumulation in the pcIC, as indicated by 
its colocalization with Rab1A, in the above described experimental conditions is shown in Figure 
8B. 10 min of BFA treatment (control) is sufficient to redistribute the bulk of Man II to the ER, 
and only very few cells show Man II-positive pcICs. However, after the 3 h NH4Cl pretreatment, 
approximately 55% of the cells exposed to BFA for 10 min show Man II accumulation in the 
pcIC. By 30 min of BFA treatment, this value decreases to approximately 20%, with the majority 
of cells instead showing an ER-like distribution of Man II. The observed preferential 
accumulation of Man II in the pcIC at early time points after BFA addition strengthens the 
conclusion that NH4Cl causes a delay in Man II redistribution to the ER. 
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Figure 8. Effect of NH4Cl on BFA-induced redistribution of Man II from Golgi to the ER. (A) NRK cells 
expressing GFP-Rab1A were treated for 10 or 30 min with BFA (5 µg/ml) after 3 h pretreatment with NH4Cl (10 
mM) and labeled with polyclonal anti-Man II. Rab1A is shown in green, Man II in red, and colocalization is 
indicated by the yellow color. Scalebars: 10 µm. (B) The percentage of cells showing colocalization of Man II with 
Rab1A in the pcIC was determined for each condition (n=100). 
 
The cells exposed to the different experimental conditions (Figure 8) displayed considerable 
variability in the extent of Man II accumulation in the pcIC. Therefore, the pcIC pools of Man II 
were quantified more precisely to yield numerical values corresponding to the relative amounts of 
the protein. This allowed more accurate comparison of the different conditions, thus providing a 
better assessment of the effect of NH4Cl on BFA-induced Man II redistribution. For each sample, 
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the pixel intensity of Man II fluorescence within the region of interest (ROI) defined by the 
Rab1A-positive pcIC was measured using standard Leica confocal software. Figure 9A 
illustrates the application of this method in the case of control cells (BFA alone, 10 min), 
showing the ROIs drawn around each separate pcIC defined by Rab1A. Subsequently, the pixel 
intensities of the selected ROIs were calculated by measuring the fluorescence intensity within 
the Man II channel (red) for each optical section. Since the size of the pcIC varies between 
different cells (and may also be affected by the different experimental conditions), the resulting 
total fluorescence signals were divided by the areas of the corresponding ROIs. The obtained 
values, representing the average pixel intensities per unit area, provide more accurate estimates of 
the pcIC pools of Man II under the different experimental conditions. 
 
The relative amounts of Man II present in the pcIC at various times after BFA addition (0, 5, 10, 
20, 30 min), measured by the above described method, are shown in Figure 9B. The control cells 
(exposed to BFA alone) and cells pretreated for 3 h with NH4Cl prior to BFA addition are 
indicated by the blue and red curves, respectively. Under both conditions, the pixel intensity 
gradually decreases during the 30 min of BFA treatment, resulting in the general downward 
slopes of the two curves. This finding indicates that the amount of Man II in the pcIC diminishes 
in the course of the BFA treatment, as the protein in both cases evidently redistributes to the ER. 
Importantly, these results verify that NH4Cl pretreatment of cells does not completely block the 
BFA-induced redistribution of Man II. It is noteworthy that the measured amounts of Man II in 
the pcIC prior to BFA addition are very similar for both the control and NH4Cl-treated cells. This 
is in accordance with other results showing that long-term treatment with NH4Cl does not have a 
measurable effect on the pcIC pool of Man II (data not shown). However, a significant difference 
between the control and NH4Cl-pretreated cells is observed shortly after BFA addition, being 
most pronounced after 5 and 10 min of BFA treatment and corresponding to an approximately 
two-fold difference at the 10 min time point. The larger relative amount of Man II measured in 
the pcIC of cells pretreated with NH4Cl clearly indicates that this compound interferes with the 
BFA-induced redistribution of the protein. By 30 min of BFA treatment, the pixel intensities 
determined for control and NH4Cl-pretreated cells become more similar, which is consistent with 
the above described results indicating that NH4Cl partly inhibits the redistribution of Man II to 
the ER. In control cells, the redistribution of Man II to the ER is nearly complete after 30 min of 
BFA treatment. 
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Figure 9. Determination of the relative amounts of Man II in the separate pcICs (ROIs) after BFA addition in 
the absence or presence of NH4Cl. (A) NRK cells stably expressing GFP-Rab1A were incubated for 3 h in the 
absence or presence of NH4Cl (10 mM) and subsequently treated with BFA (5 µg/ml) for 0, 5, 10, 20, and 30 min. 
The cells were fixed, stained with polyclonal anti-Man II, and examined by confocal microscopy. Pixel intensities 
were determined for each optical section (5-7 sections, 0.3-0.4 µm in thickness) by measuring the Man II-specific red 
fluorescence (right panel) in regions of interest (ROIs) defined by the separate Rab1A-positive pcICs at the cell 
center (left panel). The images show control cells treated for 10 min with BFA. (B) Average pixel intensities per unit 
area (n=20) were plotted for the indicated time points after BFA addition.  
 
In conclusion, the above results strongly indicate that acidification facilitates the BFA-induced 
redistribution of Man II from Golgi apparatus to the ER. Interestingly, treatment of cells with 
NH4Cl results in the accumulation of Man II in the pcIC, suggesting that neutralization of the 
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lumenal pH of this organelle interferes with the proper sorting of Man II to retrograde transport 
carriers. Notably, the inhibitory effect of NH4Cl is only temporary, since after 30 min of BFA 
treatment, the accumulation of Man II in the pcIC, as compared to control cells, is considerably 
less pronounced than after short (5 to 10 min) treatments with the drug. Moreover, after 30 min of 
incubation with BFA, the number of cells showing Man II accumulation in the pcIC is 
considerably reduced (Figure 8).  
 
5.2 Effect of pH neutralization on redistribution of Man II during mitosis 
 
As described above (Section 1.5), the Golgi undergoes complete disassembly during mitosis. The 
resulting Golgi haze, which mediates the partitioning of the organelle into the forming daughter 
cells, corresponds either to numerous free vesicles or Golgi components fused with the ER 40,58. 
Recent live-cell imaging of IC dynamics in NRK cells expressing GFP-Rab1A have revealed that 
the mitotic IC maintains many of its interphasic features, including its association with the 
centrosome (M. Marie, H. Dale, N. Kouprina, J. Saraste, manuscript in preparation). Notably, the 
pcIC divides at the onset of mitosis and forms large clusters that at metaphase accumulate around 
the spindle poles. The preservation of this compartment during mitosis has raised the possibility 
that the tubulovesicular IC clusters serve as way stations in the redistribution of Golgi 
components into the mitotic Golgi haze. This alternative mechanism of Golgi partitioning, 
implicating the IC in mitotic redistribution of Golgi components, contrasts with the two previous 
models described in Section 1.5.2. 
 
Interestingly, the above described experiments (Section 5.1) have provided evidence that while 
NH4Cl treatment of interphasic cells only partially blocks the redistribution Man II to the ER, it 
efficiently inhibits the relocation of the protein in mitotic cells, i.e., the formation of the mitotic 
Golgi haze. To verify this observation, steady state cultures of GFP-Rab1A-expressing NRK cells 
were treated for 60 min with NH4Cl prior to fixation, and cells at metaphase were identified by 
DAPI staining. As shown in Figure 10A, both control metaphasic cells, as well as cells treated 
with NH4Cl, contain the punctate IC clusters that typically associate with the spindle poles, 
consistent with earlier results (M. Marie, H. Dale, N. Kouprina, J. Saraste, manuscript in 
preparation). However, the localization of Man II in metaphasic cells revealed that while the 
labeling of the untreated cells is predominantly diffuse, corresponding to the mitotic Golgi haze, 
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the NH4Cl-treated cells display a significantly more punctate pattern. Furthermore, extensive 
colocalization of Man II and Rab1A was observed in the spindle region of the drug-treated cells. 
In conclusion, these results show that NH4Cl blocks the redistribution of Man II into the mitotic 
Golgi haze and results in its accumulation in Rab1A-positive metaphasic IC clusters. Thus, they 
are in accordance with the possibility that the latter serve as way stations during the redistribution 
of Golgi components. 
 
Due to the variability in Man II labeling, quantification was performed to determine more 
precisely the localization of Man II in metaphasic cells exposed to the different experimental 
conditions (Figure 10B). The distributions of the protein in untreated cells, determined for both 
the parental and GFP-Rab1A-expressing NRK cells (control), were very similar. Both cell types 
show nearly equal expression of the diffuse and punctate patterns, with a slight predominance of 
the “haze” phenotype (~55% versus 45% in the case of parental NRK cells). Notably, NH4Cl 
treatment results in a dramatic decrease in the number of cells exhibiting the “haze” phenotype 
(less than 5% for both cell types) and leads to the appearance of abnormally large structures (in 
more than 45% of cells), containing both GFP-Rab1A and Man II. Finally, NH4Cl washout 
results in considerable reduction of the number of cells expressing the large structures with a 
corresponding increase in the fraction of cells displaying the typical Golgi haze pattern. 
Importantly, similar results were obtained for the GFP-Rab1A-expressing cells and the parental 
NRK cells, in which endogenous Rab1 was localized using affinity-purified antibodies. Overall, 
the quantification of Man II localization in metaphasic cells verified that NH4Cl treatment blocks 
the redistribution of the protein into the mitotic haze, resulting in its efficient arrest in the Rab1A-
containing mitotic IC clusters. In addition, these results are in agreement with previous studies 45 
in showing that the effect of this compound on protein sorting and/or transport is reversible. 
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Figure 10. Effect of NH4Cl on mitotic redistribution of Man II. (A) Steady state cultures of NRK cells expressing 
GFP-Rab1A were treated for 60 min with NH4Cl (10 mM) and stained with polyclonal antibodies against Man II. 
Mitotic cells at metaphase were identified by DAPI labeling. Rab1A and Man II are shown in green and red, 
respectively, and colocalization is indicated by the yellow color. Scalebars: 10 µm. (B) Quantification of Man II 
localization in parental and GFP-Rab1A-expressing NRK cells. The cultures were treated for 60 min with 10 mM 
NH4Cl, and the washout was performed by first rinsing the cells extensively with drug-free culture medium and then 
incubating them in the same medium for an additional 2 h. Man II labeling of metaphasic cells (n=200 for each 
condition) was scored as haze, puncta, or large structures according to the patterns shown in the images on the right. 
DNA staining (DAPI) is shown in blue. 
 
The effect of other acidification inhibitors on the mitotic redistribution of Man II was also 
evaluated. For this purpose, steady state cultures of GFP-Rab1A-expressing NRK cells were 
treated for 2 h with 0.5 µM bafilomycin A1 (Figure 11A) or 100 µM chloroquine (Figure 11B). 
Notably, incubation of cells in the presence of these inhibitors resulted in the accumulation of 
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Man II in large Rab1A-positive membrane clusters in metaphasic cells, similar to the structures 
seen in NH4Cl-treated cells. Thus, pH neutralization with different compounds appears to result 
in a general arrest of Man II in the mitotic IC clusters, blocking its dispersal into the Golgi haze. 
Importantly, the similar results obtained with the different inhibitors indicate that the efficient 
transport arrest exerted by NH4Cl in mitotic cells is not due to indirect effect(s) of the drug. In 
summary, the collective results obtained using confocal microscopy are in accordance with the 
conclusion that lumenal acidification of the IC plays a significant role during the relocation of 
Man II during mitosis. Generally, the IC clusters could act as way stations during the 
redistribution of Golgi proteins, providing a basis for an alternative model of mitotic Golgi 
partitioning.  
 
Figure 11. Effect of bafilomycin A1 and chloroquine on the redistribution of Man II during mitosis. NRK cells 
expressing GFP-Rab1A were treated for 2 h either with (A) 0.5 µM bafilomycin A1 (Baf A1) or (B) 100 µM 
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chloroquine (CQ) and stained with monoclonal antibodies against Man II. Rab1A and Man II are shown in green and 
red, respectively, and colocalization is indicated by the yellow color. DNA staining (DAPI) is shown in blue. 
Scalebars: 10 µm. 
 
To validate the confocal results showing increased colocalization of Man II with Rab1A after the 
treatment of mitotic cells with acidification inhibitors, cell fractionation of both control and 
NH4Cl-treated cells was performed. These pilot experiments involved steady state cultures of 
parental NRK cells and the isolation of mitotic cells by mechanical shake-off. Unfortunately, 
since cell synchronization was not employed, only small amounts of material were recovered in 
the fractions collected from the glycerol gradients (see Section 4.4.3), and as a consequence, the 
proteins of interest could not be detected by Western blotting. 
  
5.3 Effect of brefeldin A on redistribution of Man II during mitosis 
 
To complement the above results obtained using acidification inhibitors, the effect of brefeldin A 
(BFA) on the mitotic redistribution of Man II was examined in subsequent experiments. These 
studies were partly based on the surprising observation of Nizak and coworkers 72, showing that 
the addition of BFA during the prometaphase-metaphase transition (via microinjection of 
individual living mitotic cells) results in the accumulation of Golgi enzymes in BFA-resistant 
membranes of unknown nature. By contrast, microinjection of the drug during anaphase, 
telophase, or cytokinesis lead to the expected redistribution of the enzymes to the ER, as similarly 
observed during interphase 72. Since recent studies of interphasic cells revealed that the IC is a 
BFA-resistant organelle 7, it was of interest to investigate whether the BFA-resistant, Golgi 
enzyme-containing structures observed by Nizak and coworkers 72 correspond to the Rab1A-
positive IC clusters that persist and maintain their BFA-insensitivity during mitosis.  
 
To study the mitotic effects of BFA and the previously described acidification inhibitors, several 
pilot experiments were carried out in order to design an assay that would facilitate the 
morphological investigation of large numbers of cells undergoing early steps of mitosis. 
Optimally, such a method should generate a wave of cells progressing from prophase (or 
prometaphase) to metaphase in a relatively synchronized fashion, thus providing a kinetic assay 
(i.e., a short “time window”) that allows detailed evaluation of the effects of inhibitors on mitotic 
relocation of Golgi components. As one attempt to devise such an assay, steady state cultures of 
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NRK cells grown on glass coverslips were subjected to careful, but sufficiently extensive flushing 
with ice-cold medium, which was expected to selectively remove the less adherent mitotic cells 
(metaphase, anaphase, and telophase), but not detach the more tightly substrate-bound cells 
(interphase, prophase, prometaphase, and cytokinesis). Subsequently, the cells were returned to 
warm growth medium and fixed at the indicated time points after incubation at 37oC (0, 15, 30, 
and 60 min). As shown in Figure 12, the flushing of the cultures resulted in efficient detachment 
of practically all metaphasic cells, as determined by DAPI staining of cultures fixed at the 0 min 
time point, as well as most cells undergoing anaphase and telophase (data not shown). However, 
the number of metaphasic cells rapidly increased during the post-flush incubation, reaching a 
plateau (~200 metaphasic cells per coverslip) after about 30 min at 37oC (Figure 12, control). 
 
Since the flush assay appeared to fulfill the above described methodological requirements, it was 
first applied to investigate the possible effects of inhibitors on mitotic progression of NRK cells. 
Accordingly, BFA (5 µg/ml) and NH4Cl (10 mM) were added to the cells immediately after the 
removal of mitotic cells by flushing, and samples were recovered and fixed after different times 
of incubation at 37oC in the drug-containing medium. The data obtained with untreated cells 
(Figure 12, control) indicated that the metaphasic cells that eventually appear in the presence of 
BFA or NH4Cl would have been exposed to the inhibitors only during a short time period, as they 
progressed through the early steps of mitosis. Importantly, determination of the number of 
metaphasic cells by DAPI staining revealed that neither of the drugs exerts a block on early 
mitotic progression. On the contrary, both the BFA- and NH4Cl-treated cultures generated a new 
wave of metaphasic cells very rapidly. In both cases, the number of metaphasic cells reached a 
maximum already after 15 min (Figure 12, BFA and NH4Cl), i.e., with kinetics that are 
considerably faster than observed for the control cells. However, although these preliminary 
results indicate that the drugs may affect the kinetics of mitotic progression, further studies are 
required to verify this conclusion. 
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Figure 12. Application of the flush assay to study the effects of BFA and NH4Cl on mitotic progression of NRK 
cells. In order to generate a wave of cells progressing through the early steps of mitosis towards metaphase, parental 
NRK cells grown on glass coverslips were subjected to extensive flushing with ice-cold medium to release the less 
adherent mitotic cells. The cultures were then incubated for the indicated times (0, 15, 30, or 60 min) at 37oC in 
normal growth medium (control, blue), or medium supplemented with BFA (5 µg/ml, red) or NH4Cl (10 mM, green). 
The number of metaphasic cells per coverslip, both remaining bound to the cell monolayers after the flushing (0 time 
point) and appearing during the different incubations, was determined for each time point after fixation and DAPI 
staining. 
 
Nevertheless, since the flush assay provided a valuable means to generate a relatively 
synchronized wave of cells progressing towards metaphase, it could be readily applied to study 
the effect of BFA on the mitotic redistribution of Man II in GFP-Rab1A-expressing NRK cells. 
Previous results (see Figure 10A) have indicated that while the majority of control NRK cells at 
metaphase display a diffuse Man II pattern corresponding to the mitotic Golgi haze, many cells 
also contain variable amounts of large Man II-containing structures that typically localize to the 
vicinity of the spindle poles. Notably, these puncta are also positive for Rab1A, indicating that 
they correspond to the mitotic IC clusters (shown in Figure 13A). By contrast, the metaphasic 
cells appearing in BFA-treated cultures display much more extensive accumulation of Man II in 
these punctate, Rab1A-containing structures. Because BFA does not block mitotic progression 
and the flushing efficiently removes the metaphasic cells (Figure 12), this dramatic effect of the 
drug is most likely exerted at an earlier stage of mitosis, i.e,. as the cells progress towards 
metaphase. This observation supports the conclusion that the inability of BFA to induce Man II 
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relocation to the ER during late prometaphase and metaphase 72, in contrast to other stages of the 
cell cycle, is due to the temporary presence of this Golgi enzyme in the BFA-resistant IC 
elements.  
 
The intracellular distribution of the COPI coats in the absence or presence of BFA is also 
illustrated in Figure 13B. In untreated control cells (fixed 10 min after the flush), the COPI coats 
predominantly associate with the IC clusters at the spindle poles of the nascent metaphasic cells, 
showing that mitotic progression does not affect their binding to membranes. By contrast, the 
presence of BFA in the medium during the 10 min post-flush period results in the release of the 
coats and their redistribution to the cytosol, verifying the efficacy of the drug under these 
conditions.   
 
Finally, quantification of the Man II labeling patterns in control and BFA-treated metaphasic cells 
subjected to the flush procedure was carried out (Figure 13C), employing the previously 
described criteria (see Figure 10). To obtain preparations enriched in metaphasic cells, the 
mitotic cells appearing during the 10 min post-flush period were released (by shake-off) and re-
attached to poly-L-lysine-coated coverslips. As an additional control, part of the cultures were 
treated for 30 min with BFA preceding the flush and fixed after an additional 10 min post-flush 
incubation in the presence of the drug (pre-BFA). The untreated metaphasic cells stained with 
anti-Man II consist of two main populations, displaying either the punctate or haze patterns 
(Figure 13C, control). Interestingly, in these samples, the fraction of cells containing punctate 
structures (~65%) is significantly higher than in the steady state cultures (Figure 10B, ~45%), 
suggesting that this pattern may be typical for early metaphasic cells. The fraction of cells 
displaying the haze pattern (less than 10%) is greatly reduced in metaphasic cells appearing 
during the 10 min BFA treatment. There is a corresponding increase in the number of cells 
containing large, Man II-positive structures that are typically not seen in the untreated cells. 
About 60% of the drug-treated metaphasic cells display this pattern (Figure 13C, 10 min BFA). 
Since Man II is efficiently relocated to the widespread ER network when pre-mitotic cells are 
treated with BFA, virtually all cells exposed to the drug prior to the flush exhibit a hazy pattern 
(Figure 13C, pre-BFA), which is indistinguishable from the Golgi haze of the untreated cells.  
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Figure 13. Application of the flush assay to study the effects of BFA in metaphasic cells. Following flushing, the 
parental (C) or GFP-Rab1A-expressing (A and B) cells were incubated for 10 min in the presence or absence of 
BFA. Part of the BFA-treated cultures were exposed to drug already 30 min prior to the flush (C, pre-BFA). 
Metaphasic cells reappearing after the removal were identified by DAPI staining. (A) Localization of Man II. 
Colocalization of Rab1A (green) and Man II (red) is indicated by the yellow color. (B) Localization of COPI coats 
using antibodies against β-COP. Scalebars: 10 µm. (C) Quantification of Man II patterns in metaphasic cells (see also 
Figure 10; n=100). 
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In conclusion, the above results provide strong evidence in favor of the idea that the IC functions 
as a way station during the redistribution of Golgi components, playing an important role in the 
formation of the mitotic Golgi haze. It is also noteworthy that the block exerted by BFA on the 
mitotic relocation of Man II is similar to the inhibitory effects of the acidification inhibitors (see 
Section 5.2). 
 
5.4 Effect of low temperature on Man II localization during mitosis 
 
A disadvantage of expensive drugs like BFA is that they cannot be readily employed in 
experiments that require mass preparations of unsynchronized mitotic cells (e.g., cell 
fractionation and immunoelectron microscopy). Therefore, to find additional conditions that 
affect the dynamics of Golgi proteins in dividing cells, the localization of Man II was studied in 
cells exposed to low temperature (15°C). These experiments were based on previous studies 
showing that incubation at 15°C alters the localization of peripheral Golgi proteins (e.g., giantin) 
in metaphasic cells 55; however, these studies did not address the effect of low temperature on the 
mitotic distribution of integral membrane proteins, such as Man II. To investigate the effect of 
15°C incubation on the localization of this Golgi enzyme, mitotic NRK cells expressing GFP-
Rab1A were released by mechanical shake-off and bound to poly-L-lysine-coated coverslips. 
Subsequently, the cells were placed in a 15°C water bath and incubated for 15 or 30 min in pre-
cooled medium supplemented with 20 mM HEPES (pH 7.2). Interestingly, after only a 15 min 
incubation of cells at the low temperature, considerable amounts of Man II relocate to punctate 
structures at the spindle poles, which partly colocalize with the Rab1A-positive IC clusters 
(Figure 14B, compare with Figure 14A showing control cells). This effect is also seen in cells 
incubated for 30 min at 15°C (Figure 14C). This finding suggests that the low temperature 
treatment results in the accumulation of Man II in the IC elements by preventing its normal 
dispersal into the vesicular Golgi haze, sharing similarity with the effects exerted by BFA and 
acidification inhibitors (see Sections 5.2 and 5.3). However, it is also possible that low 
temperature incubation blocks a specific step – for example, a membrane fusion event – that is 
required for mitotic Golgi disassembly.  
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Figure 14. The effect of 15°C incubation on Man II redistribution during mitosis. Mitotic NRK GFP-Rab1A 
cells were collected by shake-off and bound to glass coverslips. Subsequently, the cells were incubated for 15 min 
(B) or 30 min (C) at 15°C, fixed, and stained with polyclonal antibodies against Man II. A control metaphasic cell, 
identified by DAPI staining, is shown in (A). Rab1A is shown in green, Man II in red, and colocalization is indicated 
by the yellow color. Scalebars: 10 µm. (D) Quantification of the distribution patterns of Man II (see Figure 10B) in 
parental NRK cells incubated for 30 min at 15°C (n=100). Following the low temperature treatment, the control cells 
were further incubated for 30 min at 37°C. 
 
The effect of 15oC incubation on the distribution of Man II in metaphasic cells was quantified, as 
previously described for Figure 10B. Parental NRK cells were first incubated for 30 min in a 
15°C water bath in pre-cooled medium supplemented with 20 mM HEPES (pH 7.2). A shake-off 
was performed to obtain samples enriched in mitotic cells, which were then attached to poly-L-
lysine-coated coverslips and subsequently fixed. Control samples were prepared by returning the 
low temperature-treated cultured cells to 37°C for 30 min and then collecting the mitotic cells by 
mechanical shake-off. Interestingly, the quantification indicated that the Man II distribution 
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patterns seen in individual cells (Figures 14A-C) may not adequately describe the effect(s) of the 
15oC incubation. Namely, rather than resulting in the general accumulation of Man II in punctate 
structures in metaphasic cells, the low temperature incubation appeared to considerably increase 
the fraction of cells displaying the haze phenotype (nearly 80%). In fact, following the 15oC 
treatment, the number of cells showing punctate patterns (~25%) was reduced by approximately 
two-fold as compared to the control cells (~50%) (Figure 14D). Furthermore, the cells incubated 
at 15°C did not exhibit the abnormally large Rab1A- and Man II-positive clusters that were 
encountered in a minority (~10%) of the control cells in this experiment (Figure 14D). These 
discrepant results may be due to unprecedented effects of different preparation steps on the 
mitotic cells and make it difficult to draw reliable conclusions concerning the true effects of the 
15oC incubation (see Section 6.3). 
 
Cell fractionation provides an alternative method to compare the localizations of Rab1 and Man 
II in mitotic cells exposed to the different experimental conditions, e.g., incubation at low 
temperature or in the presence of NH4Cl. In the pilot experiment described below, the 
unsynchronized parental NRK cells were grown in large culture flasks, collected by shake-off, 
and incubated for 30 min at 15oC. The corresponding control cells (37oC) were fractionated 
immediately after the shake-off. Post-chromosomal supernatants were prepared by differential 
centrifugation and subjected to ultracentrifugation in Opti-Prep velocity gradients (see Section 
4.4.2). After collection of the gradient fractions, membranes were concentrated by 
ultracentrifugation, and the final pellets were analyzed by SDS-PAGE and Western blotting (see 
Sections 4.5 and 4.6) using antibodies against Rab1, p58, and Man II.  
 
The results are shown for the control and 15°C-treated cells in Figures 15A and B, respectively. 
Unfortunately, due to the small amounts of material recovered in the control gradient fractions, 
the antibodies against Man II and Rab1 resulted in only weak bands even after long exposure 
times. However, analysis of the 15°C-treated cells showed the enrichment and colocalization of 
Man II and Rab1 in fractions 3 and 4 at the top of the gradient. Interestingly, the enrichment of 
both Rab1 and p58 in slowly-sedimenting IC elements (fractions 3 and 4) and the additional 
presence of p58 in fast-sedimenting ER structures (fractions 6-8) are in accordance with previous 
studies of interphasic PC12 cells 71. However, since p58 is relocated to the ER during mitosis (M. 
Marie, H. Dale, N. Kouprina, J. Saraste, manuscript in preparation), the finding of a major pool of 
the protein in the IC fractions is somewhat unexpected.  
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Figure 15. Application of velocity gradient sedimentation to study the effect of 15°C incubation on the 
localization of Man II in mitotic cells. Mitotic shake-offs of parental NRK cells were fractionated directly (A, 
control) or after 30 min incubation at 15°C (B) Post-chromosomal supernatants were prepared and subjected to 
velocity sedimentation in 5-25% iodixanol (Opti-Prep) gradients. The gradient fractions (1-8) were analyzed by 
SDS-PAGE and Western blotting using antibodies against Man II, p58, and Rab1. The detected immunoreactive 
bands have expected molecular weights: Man II (~124 kDa), p58 (~58 kDa), and Rab1 (~22 kDa).  
 
Although one explanation is that in mitotic cells, p58 is localized to a particular ER domain, 
whose sedimentation properties are similar to those of the tubulovesicular IC elements, another 
possibility is that the mitotic preparation(s) in this experiment were contaminated by interphasic 
cells. These preliminary and presently inconclusive findings are discussed further in Section 6.3. 
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The studies presented in this thesis address the complex pathways and mechanisms of 
bidirectional membrane traffic at the ER-Golgi boundary, with particular emphasis on the role of 
the IC in these processes. Importantly, the results provide evidence that the IC is involved in the 
partitioning of the Golgi apparatus during mitosis, introducing a novel mechanism for Golgi 
inheritance that contrasts with the previously presented models. Furthermore, they indicate that 
the function of the IC in molecular sorting and trafficking throughout the cell cycle depends on its 
lumenal acidification, i.e., that the IC is a low pH organelle.  
 
6.1 Role of the IC in mitotic Golgi partitioning 
 
Strikingly, recent studies have revealed that the IC is an autonomous organelle, which persists 
and maintains its properties throughout the cell cycle, in particular, its close association with the 
centrosome (M. Marie, H. Dale, N. Kouprina, J. Saraste, manuscript in preparation). Live-cell 
imaging of IC dynamics in NRK cells stably expressing GFP-Rab1A showed that at the onset of 
mitosis (G2/M transition), the pericentrosomal IC (pcIC) moves away from the Golgi region and 
divides into two identical structures at prophase, in parallel with the separation of the duplicated 
centrosomes. The daughter pcICs maintain their association with the centrosomes, forming 
extensive membrane clusters at the spindle poles by metaphase. Since the IC plays an important 
role in Golgi biogenesis and maintenance during interphase, its preservation during cell division 
raises the possibility that the IC clusters are also involved in mitotic Golgi disassembly, function-
ing as way stations while the components of this organelle redistribute to form the Golgi haze. 
This new model of Golgi partitioning, implicating the IC in mitotic Golgi breakdown, is 
schematically illustrated in Figure 16 (see legend for further details). 
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Figure 16. Role of the IC in mitotic Golgi partitioning. The onset of mitosis is marked by the separation of the 
centrosome and the associated pcIC from the Golgi ribbon (Step 1). Subsequent activation of cyclin B-CDK1 leads 
to phosphorylation of several targets at the pcIC, including Rab1A and GBF1. The phosphorylation of Rab1A 
inhibits tubular trafficking to the Golgi (possibly by affecting its association with a motor protein), whereas 
phosphorylation of GBF1 releases ARF1 from membranes. Since COPI coats remain membrane-bound, the 
modification of GBF1 could selectively release a particular COPI isotype (red coats) mediating IC-to-Golgi 
trafficking, thus blocking the budding or fusion (not shown) of the corresponding COPI vesicles. Accordingly, both 
COPI- and Rab1A-dependent IC-to-Golgi traffic could be disrupted by CDK1-mediated phosphorylation events 
(Step 2). In addition, ER exit is blocked due to the modification of COPII coats (Step 3). Inhibition of steps 2 and 3 
results in the accumulation of recycling Golgi enzymes in the mitotic IC clusters (“punctate” Man II pattern), 
followed by their dispersal into the Golgi haze (“diffuse” Man II pattern) via ongoing formation of IC-derived COPI 
vesicles (green coats; Step 4). The fusion of these vesicles is blocked by CDK1-dependent phosphorylation of the 
tethering factors GRASP65 and GM130. Alternatively (or in addition), the formation of the Golgi haze could take 
place via direct COPI-mediated vesiculation of the organelle (blue coats; Step 5). This model assumes the operation 
of three different types of COPI vesicles (shown in red, green, and blue) in bidirectional trafficking in the early 
secretory pathway. The proposed inhibitory mechanisms for NH4Cl and BFA are also depicted in this model, which 
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was prepared by the author. 
 
A key feature of this model is the persistent association of the pcIC with the centrosomes during 
mitosis. This previously unrecognized connection is of importance, since centrosomes represent 
the site of activation of the mitotic kinases cyclin B-CDK1 and PLK1 73,74, which regulate the 
events leading to mitotic Golgi reorganization and fragmentation 61,63,75. As described in  
Section 1.5.1, Golgi ribbon unlinking and cisternal unstacking involve phosphorylation of 
GRASP65 by CDK1 and/or PLK1 42,56,61,62. Further Golgi breakdown into vesicular tubular 
clusters and the vesicular haze has been proposed to involve ongoing budding of COPI vesicles 
(Figure 16, step 5), whose tethering and fusion with Golgi membranes is blocked by CDK1- and 
PLK1-dependent phosphorylation of GM130 54,56,61,63. Alternatively, CDK1-mediated 
phosphorylation of Rab1A 42 and the ARF exchange factor GBF1 33 at the pcIC membranes could 
block forward transport to the Golgi (Figure 16, step 2), while allowing the transfer of Golgi 
components to the IC. In this case, phosphorylation of GRASP65 and GM130 could instead 
inhibit vesicle tethering with the IC membranes, resulting in further dispersal of Golgi 
components via formation of IC-derived COPI vesicles (Figure 16, Step 4) 39,40,56. Importantly, 
the localization of activated mitotic kinases close to the centrosomes at prophase 63 raises the 
possibility that the nearby pcIC membranes play an important role in the signaling pathways that 
initiate and monitor Golgi disassembly.  
 
The alternative model of Golgi partitioning (Figure 16) is in accordance with previous studies 
demonstrating that Golgi enzymes display striking BFA-insensitivity (i.e., failure to redistribute 
to the ER) between prometaphase and late anaphase 72,76, thus indicating that they are temporarily 
present in the BFA-resistant mitotic IC elements at this particular stage. The present results 
(Figure 13) support this conclusion by showing that BFA treatment causes the accumulation of 
Man II in large Rab1A-positive membrane clusters, indicating that the IC acts as a way station 
during the redistribution of this enzyme to the Golgi haze. Importantly, the addition of BFA prior 
to mitosis redistributes Man II to the ER, and as a consequence, nearly all metaphasic cells 
display a diffuse Man II pattern (“haze”), verifying the time dependency of the drug effect 
(Figure 13C). 
 
Notably, COPI coats maintain their association with the IC during mitosis, but can be effectively 
removed by BFA (Figure 13B). Thus, BFA most likely inhibits the dispersal of Man II into the 
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Golgi haze by blocking the formation of IC-derived COPI vesicles (Figures 16 and 17B below). 
Besides affecting the redistribution of Man II, the removal of COPI coats results in considerable 
enlargement of the mitotic IC clusters, indicating that the coats play an important role in 
determining the architecture of these structures 17,26. 
 
Interestingly, treatment of mitotic cells with three different acidification inhibitors resulted in a 
similar block in Man II relocation as observed with BFA (Figures 10A, 11A, and 11B). Since the 
inhibitors have different mechanisms of action (see Section 1.4.4), these results are unlikely to be 
indirect, but rather highlight the importance of acidification for the mitotic redistribution of Golgi 
enzymes. Previous work with interphasic cells suggested that lumenal pH is important for COPI 
vesicle formation 49. Notably, however, NH4Cl treatment does not seem to affect the binding of 
COPI coats to the mitotic IC elements (data not shown), indicating that neutralization somehow 
affects COPI function without removing the coats, possibly by preventing their normal 
detachment or vesicle fusion. Thus, like BFA, acidification inhibitors may block the mitotic 
redistribution of Golgi components by inhibiting COPI-dependent pathways (Figures 16 and 17B 
below). 
 
Surprisingly, quantification of the Man II distribution patterns in untreated metaphasic cells gave 
variable results in different experiments. While in the NH4Cl experiment with parental NRK cells 
(Figure 10B), cells exhibiting the “punctate” pattern (45%) were outnumbered by those 
displaying the “haze” (55%), the BFA experiment (Figure 13C) instead indicated that the 
punctate pattern predominates (65%). This discrepancy could be explained by methodological 
differences, i.e., the fact that in the former experiment, metaphasic cells were analyzed in situ 
after fixation of steady state cultures, whereas in the latter experiment, the cells were 
synchronized (flush assay) and released by shake-off. Moreover, it is possible that the punctate 
pattern is typical for early metaphasic cells (Figure 16), whereas the haze pattern appears at a 
later stage, reflecting the relocation of Golgi enzymes from the “puncta” to dispersed vesicles. 
Accordingly, the synchronized cells appearing early after the flush could predominantly display 
the punctate pattern, corresponding to the initial accumulation of Golgi enzymes in the IC clusters 
(see Section 7). Importantly, the above considerations may account for the findings showing that 
the metaphasic Golgi of different cell types consists of variable amounts of large vesicular tubular 
clusters and small vesicles 54. 
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6.2 Trafficking functions of the IC during different stages of the cell cycle 
 
Interestingly, although NH4Cl completely blocks the redistribution of Man II during mitosis, it 
only partially affects its relocation to the ER in BFA-treated interphasic cells (Figure 8A). These 
differential effects may be reconciled with the help of a simplified model (Figure 17), proposing 
that the trafficking functions of the IC change through the course of the cell cycle. As depicted in 
the model, studies of interphasic cells have shown that the IC consists of two functionally distinct 
parts, a vacuolar domain containing ERGIC-53/p58 and COPI, and a tubular domain enriched in 
Rab1A, in accordance with the function of this compartment in vesicular (COPI-dependent) and 
tubular (COPI-independent) trafficking 7,9,28,31,64. Furthermore, different types of COPI coats 
interacting with various SNAREs are likely to participate in the anterograde movement of cargo 
from the IC to the Golgi and in retrograde traffic to the ER 7,22,32,35-37. Although the IC appears to 
maintain its division into COPI- and Rab1A-enriched subdomains during cell division (M. Marie, 
H. Dale, N. Kouprina, J. Saraste, manuscript in preparation; see Figure 17B), live-cell imaging 
has revealed that mitotic cells lack the dynamic Rab1A-containing tubules typical for interphasic 
cells. This inhibition of tubular trafficking could be due to CDK1-mediated phosphorylation of 
Rab1A 42,77, possibly affecting its interaction with a motor protein. By contrast, COPI coats still 
bind to the mitotic IC clusters (Figure 13B), indicating that COPI-dependent pathway(s) remain 
operational. As a consequence, acidification inhibitors, such as NH4Cl, efficiently block Man II 
redistribution during mitosis by inhibiting COPI-dependent trafficking (Figure 17B), while BFA 
also gives a similar effect. 
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Figure 17. Cell cycle-dependent effects of NH4Cl and BFA on the redistribution of Golgi components. (A) 
During interphase, the IC is the site of formation of two types of transport intermediates. Its vacuolar domain, which 
contains ERGIC-53/p58 and COPI, is involved in COPI-mediated vesicular trafficking. Anterograde transport to the 
Golgi and retrograde transport to the ER are mediated by two distinct types of COPI-coated vesicles (shown in red 
and green, respectively). The tubular IC domain containing the GTPase Rab1A is involved in COPI-independent 
tubular trafficking. For simplicity, only pathways originating at the IC are shown (COPII-mediated transport from the 
ER and COPI-mediated recycling pathways from the Golgi are not included). During interphase, NH4Cl addition 
blocks the COPI-mediated pathways originating at the IC. However, COPI-independent, Rab1A-mediated tubular 
pathways remain functional and can redistribute Golgi enzymes to the ER after BFA addition. (B) The IC maintains 
its division into distinct vacuolar and tubular subdomains during mitosis. However, tubular trafficking is blocked due 
to CDK1-mediated phosphorylation of Rab1A. Furthermore, anterograde transport from the IC to the Golgi is 
blocked during mitosis, as previously suggested in Figure 16 (not shown). Nevertheless, other COPI-mediated 
pathways are likely to remain functional, as indicated by the binding of COPI coats to the mitotic IC structures. The 
treatment of mitotic cells with NH4Cl results in the accumulation of Golgi enzymes in the IC clusters by blocking 
their COPI-mediated redistribution into the mitotic haze. Similarly, BFA addition during mitosis blocks the dispersal 
of Golgi enzymes into the haze by affecting the function of the COPI coats. The model has been prepared by the 
author. 
 
Treatment of interphasic cells with BFA results in the release of membrane-bound COPI coats, 
Golgi disassembly, and the transfer of Man II to the ER, which occurs (at least partly) via the 
pcIC 7. As in mitosis, NH4Cl may interfere with COPI-dependent trafficking from the IC, for 
example, by affecting the lumenal pH conditions required for the detachment of COPI vesicles 49. 
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However, the ongoing Rab1A-mediated tubular pathways allow Man II to reach the ER in the 
presence of the drug (Figure 17A). In fact, these tubular pathways may even be enhanced, not 
only by BFA 7,17,26,31, but possibly also by NH4Cl, as shown by the increased tubulation of the 
pcIC observed after long-term treatment with acidification inhibitors (data not shown). Thus, in 
contrast to exerting a tight transport block during mitosis, NH4Cl only partially arrests BFA-
induced Man II redistribution during interphase. Notably, these results are consistent with 
previous studies on the effects of monensin and bafilomycin A1 on Man II redistribution 
following BFA treatment 7,49, suggesting that acidification of the IC lumen is required for 
retrograde trafficking.  
 
One possibility is that the delay in Man II redistribution to the ER is due to an effect of NH4Cl on 
the pcIC pool of Man II prior to BFA addition. Because this protein cycles between the Golgi and 
the pcIC during interphase 7, long-term (3 h) pretreatment with NH4Cl and the resulting possible 
effects on COPI-mediated pathways may significantly increase this pool. However, quantification 
of the Man II signal in the pcIC did not show significant differences between control and NH4Cl-
treated cells (Figure 9B). Another alternative explanation for the observed delay is that the effect 
of BFA on COPI release is reduced due to the long-term NH4Cl pretreatment, and therefore, some 
COPI-dependent pathways remain functional at early time points after BFA addition. Therefore, 
as during mitosis, NH4Cl may block COPI-dependent pathways originating at the IC, resulting in 
temporary accumulation of Man II in the pcIC. The efficacy of BFA on COPI release after NH4Cl 
pretreatment was not verified in these studies. NH4Cl may also alter tubular trafficking during 
interphase, resulting in the observed delay in Man II redistribution. These alternatives need to be 
addressed by further experiments. 
 
The effect of acidification inhibitors on the anterograde transport of CFTR, a chloride channel 
that uses an unconventional Golgi-independent pathway to reach the PM 78-80, was also examined. 
Previous studies showed that long-term BFA treatment results in CFTR relocation to the ER 78; 
however, following BFA washout, the protein is transported to the cell surface via the pcIC 7. 
Therefore, attempts were made to arrest CFTR trafficking by neutralizing the pcIC; however, the 
inhibitors did not seem to affect the transport of this protein to the PM after BFA washout (data 
not shown). Similarly, BFA washout in the presence of NH4Cl did not affect the transfer of Man 
II from the ER to the Golgi (data not shown). This may indicate that acidification only plays a 
role in retrograde trafficking from the pcIC, possibly by affecting the formation of COPI vesicles 
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49. However, the above results were not quantified, and further experiments are required to 
determine the effect of neutralizing agents on anterograde trafficking. It would also be interesting 
to study the anterograde trafficking of other cargo proteins (e.g., VSV-G, SFV-G) in the presence 
of acidification inhibitors. This could provide better insight into the distinct mechanisms of 
anterograde and retrograde trafficking at the ER-Golgi boundary. 
 
6.3 Effect of low temperature on membrane trafficking 
 
As a final note, low temperature treatment of mitotic cells appeared to increase the accumulation 
of Man II in the Rab1A-positive IC clusters (see Figures 14A-C), indicating that it blocks the 
dispersal of Man II into the Golgi haze similar to BFA and the acidification inhibitors. A previous 
study concluded that low temperature incubation (15oC) destabilizes microtubules and 
consequently disrupts the structure of the mitotic spindle 55. Therefore, low temperature-induced 
disruption of spindle integrity may block the dispersal of Man II into the mitotic haze, leading to 
its accumulation in the IC clusters at metaphase. However, low temperature may also have an 
additional effect on membrane fluidity, blocking a specific step required for Golgi disassembly, 
such as membrane budding or fusion. It has also been reported that low temperature treatment 
during interphase affects COPI binding to membranes, thereby affecting vesicle budding 17,81,82. 
A similar block in COPI budding during mitosis may lead to a block in Golgi disassembly, 
resulting in the observed pattern, i.e., Man II accumulation in large membrane clusters. 
Surprisingly, results from the subsequent quantification experiment show a completely opposite 
effect (see Figure 14D). These discrepant results may be due to the different preparation steps 
employed for the two experiments. While the low temperature effect was observed in mitotic 
cells that were first replated on coverslips prior to low temperature incubation, the quantification 
experiment was performed with shake-offs of mitotic cells treated with low temperature in situ. 
Because of these discrepancies, it is difficult to draw conclusions from these preliminary findings.  
 
 
 
 
 
 
7 Conclusions and further perspectives 
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The results presented in this thesis provide evidence in support of an alternative model of mitotic 
Golgi partitioning, indicating that the permanent IC clusters function as way stations in the 
redistribution of Golgi enzymes. The similar effects of BFA and the acidification inhibitors 
suggest that the dispersal of the enzymes into the mitotic Golgi haze is mediated by COPI 
vesicles that bud from the IC elements. Accordingly, lumenal acidification of the IC is required 
for vesicle formation, or another aspect of COPI function. Both the proposed model of Golgi 
partitioning and the effect of pH disruption on coat assembly need to be addressed by additional 
experiments. 
 
One possibility to validate the proposed mechanism of Golgi partitioning via the IC is to conduct 
the flush assay and follow in more detail Man II distribution under the synchronized conditions, 
i.e., at 5 min intervals after the flush. An initial predominance of the punctate pattern and gradual 
emergence of the haze would provide strong support for a model of Golgi partitioning involving 
the permanent IC clusters as way stations in the redistribution of Golgi components. In addition, 
it is necessary to repeat the experiment with NH4Cl by employing the flush assay in the same 
manner as with BFA, rather than exposing cells to drug pretreatment. In the experiments with 
mitotic cells, the long-term pretreatments with acidification inhibitors were adopted based on 
results obtained with interphasic cells 49, as described earlier. However, the drugs may be more 
effective in mitotic cells, and therefore, long pretreatments may not be necessary. Furthermore, 
the addition of the drug at the time of the flush will diminish the possibility of secondary effects 
resulting from the long-term treatments. It will be interesting to see whether NH4Cl addition 
immediately after flush causes rapid accumulation of Man II in the Rab1A-positive IC clusters at 
metaphase, as was observed with BFA. Finally, it will be important to repeat the cell fractionation 
experiments in order to verify Man II and Rab1 colocalization in mitotic cells by an alternative 
method. Electron microscopy should also be used to examine protein colocalization at the 
ultrastructural level. These proposed experiments would provide additional insight into the role of 
the IC in membrane trafficking during different stages of the cell cycle. 
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